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ABSTRACT 
 
 
 
 Diabetes affects millions of Americans and is caused by a disruption in β-
cell abundance or function. β-cells are one of the five types of endocrine cells 
found in the pancreas. A promising potential cellular therapy for the treatment of 
diabetes is the differentiation of human embryonic stem cells to insulin-producing 
β-cells. The study of endocrine pancreas development has been critical for the 
design of in vitro protocols for the differentiation of insulin-producing cells. The 
mesoderm is critical for the differentiation of endocrine cells and despite 
significant advances in our understanding of endocrine cell development, the 
function of the pancreatic mesodermal niche in this process is poorly understood. 
Fully elucidating the role of the mesoderm in endocrine cell development can 
greatly contribute to the design of protocols for the successful generation of 
functional β-cells in vitro.  
We have discovered a novel role for mesodermally expressed Hox6 genes 
in endocrine pancreas development. Inactivation of all three Hox6 paralogs leads 
to a dramatic loss of endocrine cells, including β-cells, as well as mild delays and 
disruptions in branching and exocrine cell differentiation. Loss of Hox6 function in 
the mesenchyme of the pancreas results in reduced expression of Wnt5a in the 
	   ix	  
pancreatic mesenchyme. This leads to subsequent loss of expression of Wnt 
inhibitors Sfrp3 and Dkk1 in endocrine progenitor cells.   
In addition to a critical role in endocrine pancreas differentiation in vivo, we 
have also shown that Hox6 function is critical for the differentiation of insulin-
producing cells in vitro. Utilizing a differentiation protocol that directs endoderm to 
insulin-producing cells, we show that mesoderm with a Hox expression profile 
appropriate for the pancreatic region is also generated. Loss-of-function of Hox6 
impairs the ability of mESCs to differentiate to insulin-producing cells in vitro, 
similar to what we observe in vivo. Further elucidation of the mechanisms 
involved in mesodermal support of pancreatic endoderm and insulin-producing 
cells will contribute to protocols to generate replacement β-cells for the treatment 
of diabetes.   
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CHAPTER 1 
 
 
INTRODUCTION 
 
 
Hox genes 
Hox genes are critically important, evolutionarily conserved, transcription factors 
that are necessary for both anteroposterior patterning of the body axis, and were first 
discovered in the fruit fly, Drosophila melanogaster (Lewis, 1978). Hox genes are 
typically expressed in a collinear manner coinciding with their location along the 
chromosome. Expression of the 3’ Hox genes occurs earlier, with a more anterior limit in 
the embryo while the 5’ genes are expressed later in development in the more posterior 
regions of the embryo (Dressler and Gruss, 1989; Duboule and Dolle, 1989; Graham et 
al., 1989; Gaunt, 1991; Izpisua-Belmonte et al., 1991; Gaunt and Strachan, 1996; 
Deschamps and van Nes, 2005; Iimura and Pourquie, 2006). This interesting pattern of 
expression led to the postulation of the Hox code in which the combination of Hox 
genes functioning at any given location along the anteroposterior (AP) axis result in 
specific morphologies (Kessel and Gruss, 1990).  
Hox gene function in AP patterning has been studied extensively utilizing both 
loss-of-function (LOF) and gain-of-function (GOF) experiments. A very interesting trend 
emerged in which LOF mutations result in anterior homeotic transformations while GOF 
mutations result in posterior homeotic transformations (Gehring, 1987; Gehring, 1993). 
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For example, in Drosophila, loss of Ubx function results in an anterior homeotic 
transformation of the T3 segment into the T2 segment (Lewis, 1978). In contrast, GOF 
of Antp results in a posterior homeotic transformation in which legs grow in place of 
antennae (Schneuwly et al., 1987).  
Hox genes are evolutionarily conserved and through a series of genome 
duplications, four complexes (HoxA, B, C, and D) of Hox genes have arisen in 
mammals (Krumlauf, 1994; Zakany and Duboule, 1999). There are 39 Hox genes 
subdivided into 13 paralogous groups based on their position along the chromosome 
and sequence similarity (Fig. 1.1)(Scott, 1992; Krumlauf, 1994). Due to the functional 
redundancy of Hox genes in a given paralogous group, many single Hox mutant mice 
exhibit little to no noticeable phenotype, however, when all genes of the same 
paralogous group are disrupted, dramatic phenotypes are revealed (Condie and 
Capecchi, 1994; Davis et al., 1995; Horan et al., 1995a; Horan et al., 1995b; 
Maconochie et al., 1996; St-Jacques and McMahon, 1996; Zakany et al., 1997; Chen et 
al., 1998; Studer et al., 1998; Chen and Capecchi, 1999; Rossel and Capecchi, 1999; 
Wellik et al., 2002; Wellik and Capecchi, 2003). Consistent with studies performed in 
Drosophila, examples of anterior homeotic transformation in LOF mutants and posterior 
homeotic transformations in GOF mutants have been shown in the vertebral column of 
the mouse. In Hox10 GOF animals there is a complete loss of ribs resulting from a 
posterior homeotic transformation of the thoracic region to the lumbar region (Fig. 1.1B, 
C)(Carapuco et al., 2005). Conversely, LOF of all three genes of the Hox10 paralogous 
group results in anterior homeotic transformation of the lumbar region to thoracic with 
more posterior rib formation (Fig. 1.1B, D)(Wellik and Capecchi, 2003). In contrast to  
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Figure 1.1. Homeotic transformations in Hox6 and Hox10 mutant mice.  
Skeletal preparations of global LOF or GOF in the Hox6 (red boxes) and Hox10 
(green boxes) paralogous groups show both anterior and posterior homeotic 
transformations respectively. (A-B) Skeletons of WT embryos show the axial skeleton 
(A) and the rib cage (B). (C) Hox10 GOF shows loss of the rib cage (green asterisk) 
in a posterior homeotic transformation. (D) Ectopic rib formation in Hox10 LOF 
animals. (E) Hox6 LOF animals have a smaller rib cage and fusion of the first rib and 
the second thoracic segment. (F-G) Hox6 GOF shows animals with ectopic ribs at the 
cervical (F) and lumbar (G) levels. The first thoracic (T1), last thoracic (T13) and first 
lumbar (yellow asterisk) are labeled for reference. Figure adapted from (Mallo et al., 
2010).	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the apparent rib-inhibiting function of the Hox10 paralogous group is the rib-promoting 
function of the Hox6 paralogous group. In Hoxb6 GOF animals there is ectopic rib 
formation into the posterior region of the embryo (Fig. 1.1A, B, F, and G)(Vinagre et al., 
2010). LOF of the Hox6 paralogous group does not result in complete loss of the rib 
cage however; the rib cage was smaller and exhibited abnormal rib phenotypes, 
including the loss of the first rib and distal fusions of ribs (Fig. 1.1B and E)(McIntyre et 
al., 2007). These data have shown that similar to Drosophila, the collinear expression 
and functional properties of Hox genes is conserved in mammals.  
Consistent with collinear expression and function in the vertebral column, Hox 
genes function in organ development coinciding with their level of expression along the 
AP axis. When Hox3 function is disrupted, the thyroid is hypoplastic and both the 
thymus and parathyroid are absent (Manley and Capecchi, 1998). When all three Hox5 
genes are disrupted, the mutant lung is significantly smaller than control lungs and 
exhibits severe proximal-distal patterning defects (Hrycaj et al., 2015). When Hoxa10 
function is disrupted, there is a homeotic transformation of the proximal 25% of the 
uterus into oviduct (Benson et al., 1996). Hox10 triple mutants also have kidney defects 
in which the kidneys lack a proper kidney capsule, and as a result, exhibit decreased 
nephrogenesis and aberrant ureter branching (Yallowitz et al., 2011). Disruption of all 
three Hox11 paralogs results in a complete loss of metanephric kidney induction (Wellik 
et al., 2002). The Hox13 group is important for the proper development prostate 
(Economides and Capecchi, 2003). Consistent with organogenesis defects at the 
corresponding AP level of expression, we have found pancreas defects in mouse 
embryos with complete disruption of the Hox6 paralogous group.  
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Pancreas development in vivo 
The pancreas is derived from the endodermal gut tube and initiates as a bulging 
of the epithelium just posterior to the stomach at E8.5 (Slack, 1995). Both a dorsal and 
ventral pancreas bud from the endodermal gut tube into the surrounding mesoderm, 
and by E12.5 the separate buds fuse to form the single organ (Fig 1.2). The 
endodermally derived tissue of the pancreas consists of two major functional 
components, an endocrine and an exocrine component. The exocrine component is 
composed of both acinar cells and ductal cells (Fig.1.2, yellow cells). Acinar cells are 
responsible for secreting digestive enzymes that are transported through the ducts and 
into the duodenum to assist in nutrient metabolism. The exocrine component makes up 
approximately 90% of the overall mass of the pancreas (Puri and Hebrok, 2010).  
The smaller, but equally important, endocrine compartment contains five distinct 
cell types that each secretes a specific hormone (Fig. 1.2, green cells). The five cells 
are termed α-, β-, δ-, ε-, and PP cells and secrete glucagon, insulin, somatostatin, 
ghrelin and pancreatic polypeptide respectively. All five types of endocrine cells are 
derived from progenitor cells that express neurogenin 3 (Ngn3), and arise from the 
ductal epithelium (Gu et al., 2002). Endocrine progenitor cells migrate out of the 
epithelium into the surrounding mesenchyme and form clusters known as the islets of 
Langerhans (Rukstalis and Habener, 2009).  
Islets are highly vascularized and endocrine cells secrete their enzymes into the 
blood stream in response to signals from the body (Puri and Hebrok, 2010). In the case 
of β-cells, insulin is secreted in response to increased blood sugar levels after a meal. 
Diabetes results when the pancreas cannot produce enough insulin in response to  
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Figure 1.2 Model of early pancreas development 
The pancreas epithelium (yellow) initiates at two separate buds, the dorsal pancreas 
(dp) and the ventral pancreas (vp). These buds grow from the gut tube into the 
surrounding mesenchyme (gray). The pancreas undergoes extensive branching 
morphogenesis at E12.5 and later developing a complex ductal network (black). 
Endocrine cells (green) derive from the epithelium and migrate into the surrounding 
mesenchyme. The pancreas is highly vascularized (red). Figure adapted from (Puri 
and Hebrok, 2010) 	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increased blood glucose, either due to an autoimmune attack on the β-cells (Type I 
diabetes), or impaired β-cell function (Type II diabetes) (Pagliuca and Melton, 2013).  
The key pancreatic transcription factor and early marker of pancreatic 
specification is Pdx1. All epithelial cells and all endocrine cells (which are derived from 
the epithelium) of the pancreas arise from Pdx1-positive cells (Gannon et al., 2000; Gu 
et al., 2002). In order for Pdx1 expression to be induced, Sonic Hedgehog (Shh) 
signaling must be inhibited in mouse and chick by notochord-derived signals that 
antagonize Shh signaling (Hebrok et al., 1998; Hebrok, 2003). A host of transcription 
factors characterize the premature pancreas epithelium and include Foxa2, Gata4, 
Hnf1b, Nkx2.2, Nkx6.1, Ptf1a, and Sox9 (Zhou et al., 2007).   
By E11.5 the pancreas bud resembles a teardrop-shaped structure of epithelial 
cells (Villasenor et al., 2010). At this point, the pancreatic epithelium contains a complex 
network of lumens termed the luminal “plexus” (Fig 1.3). The plexus undergoes 
significant remodeling and the multi-lumen network matures into a single lumen network 
(Fig. 1.3)(Villasenor et al., 2010). Isolated lumens fuse together to form longer ducts, 
while epithelial cells begin to express polarity markers such as ZO-1 on the apical, 
lumen facing side of the cell (Villasenor et al., 2010). Before epithelial branching is 
readily observed, the pancreas bud undergoes a complex series of stratification, plexus 
formation and remodeling, and cell shape and polarity changes (Villasenor et al., 2010). 
These processes eventually result in a simple cuboidal epithelium forming a complex 
single lumen branching network (Hick et al., 2009; Kesavan et al., 2009).  
Concomitant with branching, the pancreas epithelium begins to differentiate into 
separate “tip” and “trunk” domains by E12.5 (Zhou et al., 2007). The tip domain is  
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Figure 1.3 Pancreas duct development 
Pancreatic branching begins at E10.5 with the onset of microlumen formation. The 
microlumens then fuse together to form a ductal plexus, which further remodels into 
the single lumen ductal network of the mature pancreas. Figure adapted from 
(Villasenor et al., 2010). 	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initially composed of multipotent progenitor cells (MPCs) capable of producing cells of 
the acinar, ductal and endocrine lineages (Zhou et al., 2007). The tip (acinar) and trunk 
(ductal) domain are established through the dynamic expression of several critical 
transcription factors. The tip domain is characterized by the expression of Cpa1, c-Myc, 
and Ptf1a (P48) while the trunk domain expresses Hes1, Hnf1β, Sox9, Nkx6.1/6.2 
Prox1 and Onecut-1 (Jacquemin et al., 2003; Wang et al., 2005; Vanhorenbeeck et al., 
2007; Zhou et al., 2007; Solar et al., 2009; Schaffer et al., 2010; Klinck et al., 2011; 
Kopinke et al., 2011; Kopp et al., 2011). Nkx6.1 (in the trunk cells) and Ptf1a (in the tip 
cells) have an antagonistic relationship that is thought to establish the separation of the 
tip and trunk domains (Schaffer et al., 2010). After E13.5, during the secondary 
transition, tip MPCs lose their multipotency and from then on only produce acinar cells 
(Zhou et al., 2007). Trunk cells retain multipotency capabilities and continue to produce 
both ductal cells and all five lineages of endocrine cells (Zhou et al., 2007; Solar et al., 
2009; Kopinke et al., 2011; Kopp et al., 2011).  
 In mouse, endocrine cell differentiation occurs in three waves through 
development termed “transitions” (Rukstalis and Habener, 2009). The primary transition 
occurs from E8.5-E12.5 and during this step mostly glucagon-producing α-cells are 
made, but it is unclear how many of these early endocrine cells actually persist into the 
adult organ (Herrera et al., 1994; Herrera, 2000). The majority of endocrine cell 
differentiation occurs during the secondary transition, which is between E13.5-E15.5 in 
the mouse embryo. This is when the bulk of insulin-producing β-cells are generated 
(Rukstalis and Habener, 2009). This is slightly different in humans where β-cells are 
actually the first endocrine cells detected, followed by α-, δ-, and then PP-cells (Piper et 
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al., 2004; Jeon et al., 2009). During the tertiary transition, the mature endocrine cells 
migrate away from the ductal epithelium and consolidate into clusters of endocrine cells 
throughout the pancreas called the islets of Langerhans (Rukstalis and Habener, 2009). 
In the adult, endocrine cell mass is maintained by slow, steady rates of proliferation. It is 
presently unclear if an endocrine stem cell exists that can contribute significantly to the 
mass of endocrine cells (Teta et al., 2005; Teta et al., 2007).  
All endocrine cells arise from the ductal epithelium of the pancreas. Intermittent 
ductal cells begin to express Ngn3, delaminate from the epithelium into the 
mesenchyme, and mature into hormone-producing endocrine cells (Gu et al., 2002). 
Ngn3 is necessary for the differentiation of endocrine cells as shown by a failure to 
generate any cells of the five endocrine lineages in mice deficient for Ngn3 function 
(Gradwohl et al., 2000). While all five endocrine cell types arise from Ngn3-expressing 
precursors, it is not completely clear how precursor cells are instructed to form the five 
specific endocrine lineages. A current hypothesis is that not all Ngn3-positive cells have 
the same developmental potential and that spatio-temporal cues influence the lineage 
decision of each endocrine sub-type (Johansson et al., 2007; Desgraz and Herrera, 
2009; Mastracci et al., 2013). The use of tamoxifen inducible expression of Ngn3 in 
Pdx1+ epithelium, in an Ngn3 -/- background, has shown that at different time points, 
different endocrine cell lineages are induced to differentiate (Johansson et al., 2007). At 
E8.5, primarily α-cells are formed (Schwitzgebel et al., 2000; Johansson et al., 2007). 
Between E10.5 and E12.5 β- and PP-cells begin to differentiate (Johansson et al., 
2007). Lastly, δ-cells only differentiate at E14.5 and later (Johansson et al., 2007). The 
molecular mechanisms involved in this temporal differentiation scheme are still not fully 
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understood although it has been shown that the mesenchyme plays a role in the timing 
of β-cell differentiation (Duvillie et al., 2006; Attali et al., 2007).  
 
The role of the mesenchyme in pancreas development 
The mesenchyme is critical for the growth and development of both the exocrine 
and endocrine pancreas. The importance of the mesenchyme has been appreciated 
since the 1960’s when initial studies found that in culture, the epithelium of the pancreas 
failed to grow when separated from the mesenchyme (Golosow and Grobstein, 1962; 
Rutter et al., 1964; Wessells and Cohen, 1967). Culture experiments like these have 
shown critical roles for the pancreas mesenchyme in both exocrine and endocrine cell 
growth and differentiation (Gittes et al., 1996; Miralles et al., 1998; Miralles et al., 1999b; 
Li et al., 2004; Duvillie et al., 2006). Cultures in which there was a close proximity of the 
epithelium to the mesenchyme promoted exocrine, but not endocrine, development (Li 
et al., 2004). When epithelium devoid of mesenchyme was cultured in Collagen I gel 
with mesenchyme on the opposite side of a diffusible filter, endocrine cell differentiation 
was promoted (Li et al., 2004). Further studies have shown that the endocrine-inhibiting 
signals induced by epithelial-mesenchymal cell-cell contact are mediated by Notch 
signaling through the expression of Hes1 and the inhibition of Ngn3 (Shih et al., 2012).  
The pancreas epithelium branches into the mesenchyme at E12.5 making it 
extremely difficult to physically separate the mesenchyme from the epithelium. Genetic 
tools are therefore necessary to further explore the mechanisms of mesenchymal-
epithelial crosstalk later in development. Recently, genetic ablation of the mesenchyme 
with diphtheria toxin was demonstrated using Nkx3.2-Cre to drive expression of 
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diphtheria toxin receptor specifically in the mesenchyme of the embryonic pancreas 
(Landsman et al., 2011). When the mesenchyme is ablated early in development, there 
is a drastic reduction in overall pancreas mass and endocrine cell mass (Landsman et 
al., 2011). Even when the mesenchyme is ablated as late as E16.5 there is a significant 
reduction in pancreas mass at E18.5 (Landsman et al., 2011). While it has been known 
for over 60 years that the presence of mesenchyme is necessary for pancreas 
development, the specific signaling mechanisms involved are largely unknown.  
 
Signaling in pancreas development 
Fgf10 is produced by mesenchymal cells and activates Fgfr2 in the epithelial 
cells (Bhushan et al., 2001; Dichmann et al., 2003; Seymour et al., 2012). Fgf signaling 
is critical for the proliferation and expansion of the exocrine pancreas, but appears to 
have little to no effect on the development of the endocrine pancreas (Miralles et al., 
1999a). When cultured in the absence of mesenchyme, treatment of the epithelium with 
Fgf1, Fgf7 or Fgf10 protein could rescue exocrine cell expansion, but there was no 
effect on the development of the endocrine compartment (Miralles et al., 1999a). While 
Fgf plays a critical role in pancreas development, the overall level of Fgf10 is barely 
detectable by E13.5 (Bhushan et al., 2001; Elghazi et al., 2002). Further studies have 
shown important roles for Retinoic Acid (RA), Wnt, Bmp, Notch, Tgfβ, and Egf signaling 
as critical mesenchymal regulators of epithelial pancreas development however, little is 
known about the function of individual members of these pathways (Stafford et al., 
2006; Tulachan et al., 2006; Jonckheere et al., 2008; Ahnfelt-Ronne et al., 2010).  
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Notch signaling is important for maintaining progenitor cells of the pancreas in an 
undifferentiated state, and can be activated by mesenchymal Fgf signals (Hart et al., 
2003; Norgaard et al., 2003). Inactivation of Notch components leads to the accelerated 
differentiation of endocrine cells, indicating a critical role for Notch signaling in 
determining the decision between endocrine and progenitor/exocrine cell fates 
(Apelqvist et al., 1999). Conversely, sustained activation of Notch signaling results in a 
loss of differentiated acinar and endocrine cells because the progenitor cell population 
remains locked in an undifferentiated state (Hald et al., 2003; Murtaugh et al., 2003).  
Tgfβ is also critical for regulating the exocrine/endocrine fate decision (Miralles et 
al., 1998). Pancreatic rudiments cultured without mesenchyme show an increase in 
exocrine cell differentiation and a decrease in endocrine cell differentiation when treated 
with the Tgfβ inhibitor follistatin (Miralles et al., 1998). Tgfβ signaling is also functional in 
human β-cells as shown by a study in which cultured human islets were treated with 
Nodal and a modest increase in β-cell proliferation was observed (Boerner et al., 2013). 
Egf signaling has roles in both exocrine and β-cell growth and abundance. Betacellulin 
is an Egf family member expressed in the pancreas epithelium at E11.5 (Thowfeequ et 
al., 2007). Betacellulin has been shown to induce proliferation of undifferentiated 
epithelial cells in human fetal pancreas and can induce proliferation of Pdx1-positive 
epithelium in mouse pancreas cultures (Demeterco et al., 2000; Thowfeequ et al., 
2007). Egf ligand is an important regulator of epithelial-mesenchymal interactions and 
can induce duct development in cultured embryonic pancreas (Warburton et al., 1992; 
Sanvito et al., 1994).  
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The mesoderm also produces signals to induce pancreas specification by 
activating the expression of Pdx1. RA and Bmp/activin signals are produced in the 
mesoderm and are sufficient to induce Pdx1 expression in otherwise non-pancreatic 
endoderm (Kumar et al., 2003). RA from the mesoderm also helps to establish the AP 
position of the liver and the pancreas (Kumar et al., 2003).  
Wnt signaling is another important developmental signaling pathway with many 
components expressed in the pancreatic mesenchyme (Heller et al., 2002). Early 
studies have shown the expression of Wnt ligands Wnt2b, Wnt4, Wnt5a, and Wnt7b, 
and many Frizzled receptors and inhibitors throughout the epithelium and mesenchyme 
of the developing pancreas (Heller et al., 2002). To date, Wnt5a and Wnt7b knockout 
mice are the only Wnt ligand specific knockouts to exhibit a pancreas phenotype (Kim et 
al., 2005; Afelik et al., 2015). Wnt5a null embryos exhibit normal overall morphology and 
exocrine cell development (Kim et al., 2005). However, endocrine cells exhibit aberrant 
islet organization and impaired migration (Kim et al., 2005). Wnt7b knockout mice 
exhibit pancreatic hypoplasia due to a lack of proliferation of pancreatic progenitor cells 
(Afelik et al., 2015).  
More studies have been done that manipulate the Wnt signaling pathway in a 
broader sense by activating or inactivating the necessary canonical Wnt component, 
β-catenin. These studies have produced sometimes directly conflicting results 
demonstrating the complexity of the canonical Wnt signaling pathway in pancreas 
development. Three separate groups have investigated the effects of an early, epithelial 
deletion of β-catenin using two different conditional deletion alleles of β-catenin and 
three different Pdx1-Cre deletor mice (Murtaugh, 2008). A study from the Melton lab 
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reported a hypoplastic pancreas with no apparent endocrine cell defects (Murtaugh et 
al., 2005). A separate study demonstrated endocrine cell loss with some exocrine cell 
defects and perinatal pancreatitis when β-catenin was deleted in the pancreas 
epithelium by a different Pdx1-Cre mouse (Dessimoz et al., 2005). Lastly, another group 
reported pancreas hypoplasia similar to the Melton group with acinar to ductal 
metaplasia and no apparent endocrine cell defects (Wells et al., 2007). This 
discrepancy in phenotype was resolved by a direct comparison of two different Pdx1-
Cre drivers which determined that the two Cre drivers induced recombination at slightly 
different time points and with varying efficiency (Heiser et al., 2006).  
These studies have shown a clear requirement for β-catenin in acinar cell 
formation early in development, but the role of Wnt signaling specifically in endocrine 
cell development is still unclear. β-catenin appears to encourage endocrine cell 
development only in an indirect fashion. In addition to the study previously mentioned by 
Dessimoz et al., a more recent study has shown that deletion of β-catenin function in 
the pancreas epithelium results in decreased β-cell mass as a result of lost MPCs 
(Baumgartner et al., 2014). This study also rules out a direct contribution of β-catenin to 
endocrine cell development by specifically deleting β-catenin in Ngn3+ endocrine 
progenitor cells and reporting no change in β-cell mass (Baumgartner et al., 2014). 
Canonical Wnt activity may in fact be inhibitory for endocrine cell differentiation. A 
surprising number of Wnt inhibitors are expressed in endocrine cells, and excess 
canonical Wnt activity results in reduced endocrine cell differentiation (Heller et al., 
2002; Pedersen and Heller, 2005). GOF of canonical Wnt ligand Wnt7b in the pancreas 
also results in failed differentiation of endocrine cells (Afelik et al., 2015). 
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Multiple Wnt pathway receptors including Fzd2, Fzd3, and Fzd7 are expressed in 
endocrine cells of the pancreas, which suggests that Wnt ligands can act directly on 
endocrine cells (Heller et al., 2002). In zebrafish, noncanonical Wnt ligand Wnt5a 
activates Fz-2 to promote proper endocrine cell development (Kim et al., 2005). Other 
members of the noncanonical Wnt planar cell polarity (PCP) pathway, Celsr2 and 
Celsr3, are necessary for the differentiation of all five types of endocrine cells (Cortijo et 
al., 2012). This growing body of evidence suggests that the proper combination of 
canonical Wnt inhibition and noncanonical PCP activation is necessary for pancreatic 
endocrine cell formation during pancreas organogenesis. The multitude of Wnt 
components expressed in the pancreas during development and the extreme 
phenotypes observed with manipulation of Wnt/ β-catenin signaling suggests an 
extremely complicated signaling network of which we are only beginning to understand. 
 
Differentiation of ESCs to insulin-producing cells in vitro  
The study of pancreas development, and especially the signals critical to inform 
proper endocrine pancreas development, is necessary to design efficient protocols of 
embryonic stem cell (ESC) or induced pluripotent stem cell (iPSC) differentiation to 
glucose responsive insulin-producing cells for the treatment of diabetes. Diabetes is a 
metabolic disease that can occur in multiple different ways. Type I diabetes is caused 
by the autoimmune destruction of pancreatic β-cells. Type II diabetes occurs when 
consistently high blood sugar creates an excessive demand for insulin, which in turn 
leads to β-cell malfunction, de-differentiation and apoptosis (Ashcroft and Rorsman, 
2012; Talchai et al., 2012). Diabetes leads to devastating side effects including 
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cardiovascular disease, retinopathy and blindness, amputations caused by neuropathy, 
kidney disease and eventual renal failure (Pagliuca and Melton, 2013). One of the most 
common treatments for diabetes is the administration of exogenous insulin. Insulin 
injections are necessary for the treatment of Type I diabetes especially, and requires 
several blood glucose measurements and insulin injections per day. This is a taxing 
treatment option for the patient, and if not monitored properly, can lead to devastating 
side effects including ketosis and coma (Nathan et al., 2009).  
 The prospect of ESC- or iPSC-derived β-cells for the treatment of diabetes is 
appealing because it is only a single cell type that needs to be replaced and if 
successful, could eliminate the diabetic patient’s requirement for exogenous insulin 
(Pagliuca and Melton, 2013). There is precedent for the concept of using ESC-derived 
mature cell types for the treatment of disease as techniques have been utilized for other 
organ systems as well. ESC-derived cardiomyocytes have been used to engraft onto 
injured hearts and prevent arrhythmias (Shiba et al., 2012). Another example is ESC-
derived oligodendrocytes that have been able to restore mobility to rats with spinal cord 
injuries (Keirstead et al., 2005).  
 While replacement β-cells would be of great benefit to those with Type II 
diabetes, there is still the problem of an autoimmune attack on replacement β-cells in 
patients with Type I diabetes. The recipient’s immune system would also attack 
replacement β-cells from a donor. Fortunately, replacement β-cells could be 
transplanted to non-endogenous sites allowing those cells to be enclosed in immune-
protective devices (Pagliuca and Melton, 2013). In fact, β-cells donated by human 
cadavers have been transplanted into the hepatic portal vein of the recipient with 
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successful results (Mullen et al., 1977; Lacy and Scharp, 1986; Shapiro et al., 2000; 
Shapiro et al., 2006; Bellin et al., 2012). Although the transplantation of human 
cadaveric β-cells has been a successful treatment for diabetes, the overwhelming 
demand for these cells versus their availability creates a necessity for alternate 
treatments (Pagliuca and Melton, 2013).  
 The first major step in the generation of β-cells in vitro was the identification of 
human ESCs (hESCs) (Thomson et al., 1998). This, however, caused a significant 
amount of controversy and even led to a ban of NIH funding on research involving 
newly generated hESCs (Murugan, 2009). Research on a restricted number of hESC 
lines is allowed, but this makes it difficult to study specific disease mutations that are not 
already present in accepted cell lines, and also limits the genetic diversity available for 
study (Murugan, 2009). A critical breakthrough in this area of research was the 
discovery of a method to generate iPSCs from murine fibroblasts (Takahashi and 
Yamanaka, 2006; Wernig et al., 2007; Yu et al., 2007). The generation of iPSCs from 
human cells followed shortly thereafter (Takahashi et al., 2007; Yu et al., 2007; Lowry et 
al., 2008; Nakagawa et al., 2008). Critically, iPSCs are not generated from human 
blastocysts, circumventing controversy, and these cells have the ability to generate all 
cell types (Wernig et al., 2007; Okita et al., 2010). This allows for greater funding 
flexibility and significantly expands the scientific questions that can be answered 
regarding specific genetic backgrounds/mutations. iPSCs also allow patient-specific cell 
generation to circumvent complications such as graft-versus-host disease.  
Forced expression of genes such as Pdx1 and Ptf1a are capable of converting 
non-pancreas cells into pancreas cells however, manipulating the genome of cells that 
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are to be used for transplantation into diabetic patients can lead to unintended 
mutations and consequences (Fig. 1.4B)(Afelik et al., 2006). Investigators have instead 
utilized various methods of ESC to insulin producing cell (IPC) differentiation through 
the treatment of cells with combinations of growth factors found in normal pancreas 
development in vivo (D'Amour et al., 2006). The most successful methods for the 
differentiation of IPCs in vitro mimic the sequential steps that a developing β-cell 
undergoes in vivo (Fig. 1.4A) (Pagliuca and Melton, 2013).  
All endocrine cells of the pancreas are derived from the epithelium of the 
pancreas, which in turn is derived from endoderm (Gittes, 2009). The first step in 
differentiation protocols is then to produce an abundant population of endodermal cells 
from pluripotent stem cells. The first efficient protocol for the generation of definitive 
endoderm from hESCs used Activin A, a member of the TGF-β family, to induce 
endoderm differentiation (D'Amour et al., 2005). The basis for using Activin A as a 
director of endodermal differentiation derived from studies that have shown primitive 
streak defects caused by the disruption of either the Wnt or TGF-β signaling pathways 
(Conlon et al., 1994; Haegel et al., 1995; Liu et al., 1999; Brennan et al., 2001; Kelly et 
al., 2004). Activin A in combination with low serum conditions can produce a population 
of up to 80% endodermal cells as determined by the expression of transcription factors 
such as FoxA2, Sox17, and Gsc (D'Amour et al., 2005). The dose of Activin A is also 
critical as concentrations between 50-100 ng/mL lead to efficient differentiation of 
definitive endoderm (DE) whereas lower doses do not (Kubo et al., 2004; D'Amour et 
al., 2005). Several studies have shown that treating cells with factors including Wnt 
activators (Wnt3a and CHIR9902), GSK3β, sodium butyrate, PI3K pathway antagonists,  
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Figure 1.4 Strategies for β-cell generation in vitro 
(A) Pluripotent stem cells can be directed to differentiate through sequential cell types 
to mimic normal in vivo β-cell development using a series of growth factors and small 
molecules. Until recently, an implantation in vivo differentiation step was required to 
differentiate endocrine progenitor cells in functional glucose-responsive β-cells. (B) 
Acinar or other endocrine cells can be directly reprogrammed to β-cells using 
overexpression techniques. Successful reprogramming of mature cell types from 
other organs has yet to be achieved. (C) Inducing replication in existing β-cells or β-
cells generated in vitro is another possible way to produce a large population of β-
cells for implantation into a diabetic patient. Figure adapted from (Pagliuca and 
Melton, 2013) 	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and GDF8 (a TGF-β family member) can improve the efficiency of endoderm 
differentiation (Jiang, W. et al., 2007; McLean et al., 2007; Zhang et al., 2009; Bone et 
al., 2011; Kunisada et al., 2012; Bruin et al., 2014).  
After differentiation to endoderm, the cells must further mature to pancreatic 
endoderm. All epithelial cells and all endocrine cells (which are derived from the 
epithelium) of the pancreas arise from Pdx1-positive cells (Gannon et al., 2000; Gu et 
al., 2002). As previously discussed, Shh signaling must be inhibited for Pdx1 expression 
to be induced. In addition to the repression of Shh, RA is required for pancreas 
induction and Fgf10 is required for the growth and expansion of the epithelium (Chen et 
al., 2004; Martin et al., 2005; Molotkov et al., 2005; Stafford and Prince, 2002; Bhushan 
et al., 2001). The combination of Shh inhibition, Fgf10 and RA is sufficient to 
differentiate definitive endoderm into pancreatic endoderm in vitro (D’Amour et al., 
2006).  
All pancreatic endocrine cells derive from ductal epithelium cells that begin to 
express Ngn3, and then subsequently delaminate from the epithelium, migrate into the 
surrounding mesenchyme, and mature into functional endocrine cells (Gu et al., 2002). 
The process of determining which cells along the duct begin to express Ngn3 is 
regulated by Notch signaling (Shih et al., 2012). Notch signaling promotes the 
expression of Sox9, which can then cell-autonomously activate the expression of Ngn3 
(Shih et al., 2012). This signaling mechanism is dose dependent however, as too much 
Notch activity can actually inhibit Ngn3 expression by promoting the expression of Ngn3 
repressor Hes1 instead (Shih et al., 2012). Some groups have utilized this knowledge 
and include DAPT (a gamma secretase inhibitor) to help limit Notch activity and 
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therefore promote the induction of Ngn3 expressing cells in culture (D'Amour et al., 
2006; Chen et al., 2009; Thatava et al., 2011; Pagliuca and Melton, 2013). 
A number of additional growth factors and small molecules have been used in an 
effort to induce endocrine cell differentiation from pancreatic endoderm in vitro including 
BMP inhibitors, PKC activators, EGF, KGF, and exendin-4 (D'Amour et al., 2006; Kroon 
et al., 2008; Rezania et al., 2012; Schulz et al., 2012). However, until recently, no 
combination of these factors was able to generate an abundant population of functional 
glucose-responsive insulin-producing cells. A number of groups have been able to 
generate IPCs, but there were problems with these cells such as the failure to secrete 
insulin in response to glucose, poly-hormonal expression, and lack of expression of 
Nkx6.1 and MafA (D'Amour et al., 2006; Jiang, J. et al., 2007; Jiang, W. et al., 2007; 
Shim et al., 2007; Kroon et al., 2008; Tateishi et al., 2008; Zhang et al., 2009; Cai et al., 
2010; Mfopou et al., 2010; Kelly et al., 2011; Nostro et al., 2011; Xu et al., 2011). 
Functional, glucose-responsive β-cells were only generated if the endocrine progenitor 
cells from culture were implanted into a mouse and left to further differentiate in vivo for 
four months (Kroon et al., 2008; Rezania et al., 2012).  
There has been recent success in the field of IPC differentiation as multiple 
different groups have been successful in the generation of functional glucose-
responsive insulin-producing cells in vitro (Pagliuca et al., 2014; Rezania et al., 2014; 
Russ et al., 2015). Timothy Kieffer’s group developed a seven-step protocol that was 
able to generate glucose-responsive insulin-secreting cells capable of treating diabetes 
in the mouse (Rezania et al., 2014). Doug Melton’s group generated a protocol for the 
differentiation of hESCs and hiPSCs into functional β-cells (termed SC-β cells) in vitro 
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by testing over 70 different compounds in more than 150 combinations (Pagliuca et al., 
2014). This 4-5 week protocol utilizes a three-dimensional culture method and the 
manipulation of numerous pathways including Wnt, Activin, Shh, EGF, TGFβ, thyroid 
hormone, and RA (Pagliuca et al., 2014). The SC-β cells performed just as well as 
cadaveric β-cells in terms of glucose dependent insulin-secretion and the ability to treat 
diabetes in the mouse (Pagliuca et al., 2014). These studies both report the presence of 
a large population of C-peptide-positive cells that do not express Nkx6.1 and may result 
in the rise of polyhormonal cells that can result from the early induction of endocrine cell 
differentiation in Pdx1+Nkx6.1- cells (Rezania et al., 2014; Russ et al., 2015). A study 
by Mattias Hebrok’s lab modifies these previous protocols by omitting BMP inhibitors 
and focusing on a slightly later stage in the differentiation process with the addition of 
EGF and KGF to induce a greater population of Nkx6.1 expressing cells (Russ et al., 
2015). They report that their simplified protocol enables the generation of a more 
restricted endocrine population without polyhormonal cells and more closely resembles 
the mechanisms of in vivo endocrine cell differentiation (Russ et al., 2015). It is possible 
that the omission of BMP inhibitors in this protocol allows for some mesodermal cell 
differentiation to supply additional signals to the differentiating endodermal cells to aid in 
the differentiation of endocrine cells, a topic discussed in Chapter 3 of this dissertation. 
While these studies have shown extremely promising results, there still remains the 
presence of cells that have not fully differentiated to mature, functional β-cells (Rezania 
et al., 2014; Russ et al., 2015). These remaining immature cells may cause problems if 
implanted into a diabetic patient. It is possible that fully elucidating the molecular signals 
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from the mesenchyme critical for endocrine cell differentiation will lead to protocols 
capable of differentiating pure populations of functional β-cells.  
 
Unanswered questions in the field 
Many of the factors utilized in protocols of in vitro β-cell differentiation are 
produced by the pancreatic mesenchyme (Gittes, 2009; Puri and Hebrok, 2010). In 
order to generate a pure population of functional β-cells, critical signals from the 
mesenchyme will need to be replaced in culture. This will only happen when the role of 
the mesenchyme in pancreas development in vivo is fully understood. The complexity of 
signaling between the mesenchyme and epithelium is still not well understood despite 
the fact that the mesenchyme has been known to play critical roles in pancreas 
development for more than 50 years (Golosow and Grobstein, 1962; Wessells and 
Cohen, 1967). Studies like these in the next two chapters have a significant impact on 
our understanding of mesenchymal-epithelial signaling in pancreas development.  
Signaling pathways such as Wnt have a multitude of ligands, receptors, and 
inhibitors expressed throughout pancreas development, but the function of only a few of 
these specific members has been reported (Heller et al., 2002; Kim et al., 2005; Afelik et 
al., 2015). It is likely that many of the members of this and other pathways have critical 
roles in pancreas development that will need to be elucidated. There is still the lack of a 
consensus phenotype for broader functional studies of Wnt in the pancreas that either 
block or promote overall canonical Wnt activity through the manipulation of β-catenin 
(Murtaugh, 2008). Despite the abundance of published articles on Wnt and other 
pathways there is still more to be investigated. Here we find a critical role for multiple 
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members of the Wnt signaling pathway that will ultimately contribute to our overall 
understanding in the role of Wnt signaling in endocrine pancreas development.  
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CHAPTER 2 
 
MESENCHYMAL HOX6 FUNCTION IS REQUIRED FOR PANCREATIC ENDOCRINE 
CELL DIFFERENTIATION 
 
 
Summary 
 Despite significant advances in our understanding of pancreatic endocrine cell 
development, the function of the pancreatic mesodermal niche in this process is poorly 
understood. Here we report a novel role for Hox6 genes in pancreatic organogenesis. 
Hox6 genes are expressed exclusively in the mesoderm of the developing pancreas. 
Genetic loss of all three Hox6 paralogs (Hoxa6, Hoxb6, Hoxc6) leads to a dramatic loss 
of endoderm-derived endocrine cells including insulin-secreting beta cells, as well as 
mild delays and disruptions in pancreas branching and exocrine differentiation. Ngn3-
expressing pan-endocrine progenitor cells are specified normally in Hox6 mutant 
pancreata, but fail to mature into hormone-producing cells. Reduced expression of 
Wnt5a is observed in mutant pancreatic mesenchyme, leading to subsequent loss of 
expression of critical Wnt inhibitors Sfrp3 and Dkk1 in endocrine progenitor cells. These 
results reveal a key role for Hox6 genes in establishing Wnt mesenchymal/epithelial 
crosstalk in pancreatic development. 
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Introduction 
Hox genes play a well-established role in axial and appendicular skeletal 
patterning, and knowledge of their importance in organogenesis is expanding. Hox 
genes have important roles in the development of organs that correspond to Hox 
expression along the AP axis. Examples include the Hox3 paralogous group genes, 
which are critical for thymus, thyroid, and parathyroid development, Hox5 genes in lung 
development, Hox9, 10, 11 in the reproductive tract, Hox10 and Hox11 genes in kidney 
development, and Hoxb13 for prostate development (Dolle et al., 1991; Benson et al., 
1996; Gendron et al., 1997; Taylor et al., 1997; Manley and Capecchi, 1998; Podlasek 
et al., 1999; Economides and Capecchi, 2003; Schwab et al., 2006; Yallowitz et al., 
2011; Boucherat et al., 2013; Raines et al., 2013; Hrycaj et al., 2015).  
The Hox6 paralogous group includes three genes: Hoxa6, Hoxb6 and Hoxc6. 
Paralogous Hox genes have been shown to exhibit a high degree of functional 
redundancy due to sequence similarity and significant overlap in expression. Loss of a 
single gene within a paralogous group often results in little to no observable phenotype, 
however, disruption of all members of a given paralogous group result in dramatic 
patterning phenotypes (Davis and Capecchi, 1994; Horan et al., 1995b; Fromental-
Ramain et al., 1996b; Fromental-Ramain et al., 1996a; Manley and Capecchi, 1998; 
Rossel and Capecchi, 1999; van den Akker et al., 2001; Wellik et al., 2002; Wellik and 
Capecchi, 2003; McIntyre et al., 2007; Yallowitz et al., 2009; Xu and Wellik, 2011; 
Yallowitz et al., 2011; Xu et al., 2013). Single mutant animals for each of the Hox6 
paralogs have undetectable or very mild defects, but collectively this group has been 
demonstrated to play important roles in patterning the rib cage and in neuronal cell fate 
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determination (Kostic and Capecchi, 1994; Rancourt et al., 1995; McIntyre et al., 2007; 
Mallo et al., 2010; Lacombe et al., 2013). Hox6 genes are also expressed in the 
pancreatic mesoderm suggesting a possible role for Hox6 in pancreas organogenesis.  
 In mouse, the pancreas is specified at approximately E9.5 and expands as a 
dorsal and ventral bud from the endoderm-derived gut tube into the surrounding 
mesoderm (Wells and Melton, 2000; Gittes, 2009; Puri and Hebrok, 2010). At E11.5, 
these buds fuse to become the dorsal and ventral regions of the single pancreas. The 
pancreas has two main components: an exocrine and endocrine component. The 
exocrine component is composed of digestive enzyme-secreting acinar cells and ductal 
cells. Ductal cells form a complex branching network that transports the digestive 
enzymes into the small intestine. The endocrine component is composed of five distinct 
types of endocrine cells which each secrete a single hormone: insulin, glucagon, 
somatostatin, ghrelin, or pancreatic polypeptide. Endocrine cell differentiation is initiated 
in the ductal epithelium by the expression of Ngn3 in a sub-population of the epithelial 
cells (Gu et al., 2002). These Ngn3-positive (Ngn3+) cells subsequently delaminate 
from the ductal epithelium into the surrounding mesenchyme and further differentiate to 
the specific endocrine lineages. The bulk of endocrine cell differentiation occurs from 
E12.5-E15.5, which is termed the secondary transition. While all of the major functional 
components of the pancreas are derived from the endoderm, the surrounding 
mesodermally-derived mesenchyme is critical for the growth and development of these 
cell types (Golosow and Grobstein, 1962; Gittes et al., 1996; Miralles et al., 1998; 
Bhushan et al., 2001; Attali et al., 2007; Gittes, 2009; Puri and Hebrok, 2010). 
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 Explant studies were first used to demonstrate the importance of the 
mesenchyme. When pancreas epithelium was cultured in the absence of its surrounding 
mesenchyme, both endocrine and exocrine development arrested with defects in growth 
and differentiation. These defects were rescued by recombination with pancreatic 
mesenchyme (Golosow and Grobstein, 1962; Wessells and Cohen, 1967). A more 
recent study in which the pancreas mesenchyme was genetically ablated in vivo 
showed a similar failure of all components of the pancreas to develop (Landsman et al., 
2011).  
 Wnt signaling is critical for multiple aspects of pancreas development. A 
multitude of Wnt ligands, receptors, modifiers, and inhibitors have reported expression 
in both the epithelium and mesenchyme of the pancreas, with gene expression highest 
early in development and declining with organ maturation (Heller et al., 2002). Wnt has 
largely been studied in the pancreas through manipulation of required canonical Wnt 
signaling components such as β-catenin. Others have shown specific roles for individual 
Wnt ligands, and taken together, there are significant roles for both Wnt/ β-catenin 
signaling and the non-canonical Wnt planar cell polarity pathway for the proper 
development of both endocrine and exocrine pancreas (Heller et al., 2002; Kim et al., 
2005; Murtaugh et al., 2005; Heiser et al., 2006; Attali et al., 2007; Wells et al., 2007; 
Jonckheere et al., 2008; Murtaugh, 2008; Baumgartner et al., 2014; Afelik et al., 2015). 
 While Hox genes have been shown to be important for the development of many 
organs of endodermal/mesodermal origin, a role for Hox genes in pancreas 
development has not been reported. Herein, we report that Hox6 genes function in 
pancreatic organogenesis. Hox6 genes are expressed only in the mesoderm of the 
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developing pancreas and not in the endoderm. The Hox6 mutant pancreas buds 
normally and Ngn3+ endocrine progenitors are specified, but there is a >90% reduction 
of mature endocrine cells in the Hox6 mutant pancreas compared to controls. Loss of 
Hox6 function results in a decrease in Wnt5a expression in the pancreatic mesenchyme 
(though epithelial Wnt5a expression is unperturbed). This leads to a subsequent loss of 
expression of two Wnt inhibitors, Sfrp3 (Frzb) and Dkk1, in endocrine progenitor cells. 
The addition of recombinant Wnt5a protein to pancreas explant cultures is sufficient to 
rescue endocrine cell differentiation in Hox6 mutant pancreata. Thus, regional 
mesodermal patterning factors are critical for establishing the mesenchymal/epithelial 
crosstalk required for proper endocrine cell differentiation in pancreas development, 
highlighting the potential importance of considering the mesodermal niche in ex vivo 
beta cell differentiation protocols.  
 
Results 
Pancreas specification occurs normally in Hox6 mutants with mild defects in 
morphology and acinar differentiation  
Hox6 aabbcc (lower case letters represent null alleles) mice do not survive post-
natally, however, mutant embryos are indistinguishable in appearance (Fig. 2.1A) and 
mass (Fig. 2.1B) from littermate controls. Examination of internal organ defects reveals 
somewhat abnormal pancreas morphology in Hox6 mutants compared to controls (Fig. 
2.2A). The ventral pancreas (black arrowheads) and trunk of the dorsal pancreas 
(yellow arrowheads) are more compact in Hox6 mutant pancreata compared to controls. 
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Despite mildly perturbed pancreas morphology, a normal expression pattern of acinar 
cell marker amylase (Amy) is observed in the mutant pancreas (Fig. 2.2B).  
Early stages of pancreas initiation were examined by immunofluorescent staining 
for pancreas epithelial marker Pdx1. Quantification of immunofluorescent staining of the 
entire early pancreas (dorsal and ventral bud) shows that both pancreatic buds initiate 
normally and the volume of Pdx1-positive epithelium is unchanged between the control 
and Hox6 mutant at E10.5 (Fig. 2.3A,B). A small decrease in epithelial volume was 
observed at E11.5 (Fig. 2.3A,D). Minor decreases in both epithelial and mesenchymal 
proliferation were measured at E11.5 and E14.5 (Fig. 2.3C,G), however no overall 
differences in mesenchyme volume were measured (Fig. 2.3E), and there is no overall 
change in pancreas mass at E18.5 regardless of Hox6 genotype (Fig. 2.3H). There 
were no differences in apoptosis measured by cleaved Caspase-3 staining (Fig. 2.3I).  
Examination of morphological defects at E14.5 by staining with E-cadherin 
(Ecad) reveals typical loose, lobular branching epithelium in the control pancreas, but 
more compact clusters of epithelial cells with less branching in the mutant pancreas 
(Fig. 2.2C). Branch pattern was further analyzed at E14.5 using Muc-1 antibody staining 
in whole pancreata (Villasenor et al., 2010). Hox6 null pancreata exhibit impaired 
branching and apparent defects in the remodeling of the early ductal plexus (Fig. 2.2D). 
Many thin, single lumens have resolved throughout the control pancreas while these 
lumens are less apparent in the mutant (Fig. 2.2D, red arrowheads). Bright, dense 
staining for Muc-1, indicating acinar clusters, is found readily throughout both control 
and Hox6 null pancreata (Fig. 2.2D, white arrowheads). 
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Prior to E13.5, the “tip” acinar cells of the pancreas are multipotent progenitor 
cells (MPCs) and can produce exocrine, ductal, and endocrine cells. All epithelial cells 
at these early stages express Sox9 and Hnf1β. After E13.5, as Sox9 and Hnf1β are 
down regulated in tip cells, these cell types become unipotent and only give rise to 
acinar cells (Zhou et al., 2007; Kopp et al., 2011). In contrast to controls, Hox6 mutant 
pancreata demonstrate continued Sox9 and Hnf1β in Cpa1-positive tip cells at E14.5 
(Fig. 2.2E,F). This is resolved by E16.5, consistent with the eventual differentiation and 
maturation of MPCs into mature exocrine acinar cells. This defect may be related to the 
perturbed morphology and branch pattern observed in mutants. 
 
Endocrine differentiation is inhibited in Hox6 mutant pancreata 
The mild defects in branching and in exocrine differentiation are in contrast to a 
dramatic reduction of all five mature endocrine cell hormones in Hox6 mutant pancreata 
(Fig. 2.4A,B). Antibody staining for insulin (Ins) and glucagon (Gcg) reveals a dramatic 
reduction of both endocrine protein and mRNA expression of all five endocrine 
hormones at E14.5 (Fig. 2.4A). This decrease is more pronounced by newborn stages 
with Ins and Gcg mRNA expression reduced to less than 5% of control values (Fig. 
2.4B).  
All five endocrine cell types derive from Ngn3+ cells that arise from the ductal 
epithelium. During pancreatic development, sporadic ductal cells express Ngn3, 
initiating a delamination process and allowing these cells to migrate into the surrounding 
mesenchyme where they mature into the five types of hormone-producing cells. We 
investigated the cellular defects leading to the dramatic decrease of endocrine cells in 
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the mutant by examining the initiation and differentiation of this cell type. There is no 
change in the amount of Ngn3+ immunofluorescent staining (Fig. 2.5A) or expression of 
Ngn3 mRNA by qRT-PCR (Fig. 2.5D) in the mutant pancreas compared to controls. 
There were also no measured changes in expression of Nkx6.1 or Nkx2.2 (Fig. 2.5D), 
however, these genes are expressed more broadly in the epithelium (Sussel et al., 
1998; Schaffer et al., 2010). There are significant reductions of pan-endocrine markers 
ChgA and Isl1 protein and mRNA at E14.5 (Fig. 2.5B-D). The mRNA expression of 
endocrine lineage genes MafA, MafB, and NeuroD are also significantly reduced (Fig. 
2.5D). Despite the apparent loss of endocrine differentiation, Ngn3 staining in controls 
and mutants is comparable, suggesting that Ngn3+ progenitor cells do not accumulate 
in Hox6 mutants through E18.5 (Fig. 2.6).  
In the first phase of endocrine differentiation, sporadic Sox9-positive (Sox9+) 
ductal cells begin to additionally express Ngn3, allowing these cells to delaminate from 
the epithelium while concomitantly turning off Sox9 expression (Gouzi et al., 2011; Shih 
et al., 2012). We examined this process by antibody staining control and Hox6 mutant 
pancreata for Ngn3 and Sox9. Immunostaining reveals that about 25% of Ngn3+ cells 
are also Sox9+ in control pancreata at E14.5 (Fig. 2.5E, yellow arrows). This ratio is 
identical in the Hox6 mutant pancreas, providing evidence that endocrine progenitor 
cells are able to adequately transition from Sox9+/Ngn3+ ductal cells into Sox9-/Ngn3+ 
early endocrine cells (Fig. 2.5E). Ngn3+ cells that have successfully migrated from the 
duct are observed throughout the control and in the Hox6 mutant pancreas (Fig. 2.5E, 
white arrows), further supporting a differentiation defect post-specification and 
delamination.  
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Hox6 genes are expressed in the mesoderm of the pancreas during development 
All three Hox6 genes are expressed in the embryonic pancreas with expression 
highest early in development, persisting through E16.5 (Fig. 2.7A). Expression was 
below our limit of detection for all three Hox6 genes at E18.5 (Fig. 2.7A). In situ 
hybridization analyses of Hox6 mRNA reveal expression exclusively in the pancreas 
mesoderm at E11.5 and E12.5 (Fig. 2.7B). Mesodermally restricted expression was 
confirmed using a previously reported Hoxb6-inducible Cre reporter line 
(Hoxb6CreERT;Rosa26-tdTomato) (Nguyen et al., 2009; Madisen et al., 2010). 
Administration of tamoxifen at early stages (E9.5 and E10.5) reveals an anterior 
expression limit at the level of the budding dorsal and ventral pancreas, and also marks 
the majority of mesoderm posterior to this in the embryo (Fig. 2.7C).  
Expression from the ROSA locus in these mice is observed throughout the 
pancreatic mesenchyme, but is completely excluded from early Ins-positive endocrine 
cells, Pdx1-positive pancreas endoderm, and PECAM-positive vasculature (Fig. 2.7C). 
As endocrine cells undergo epithelial to mesenchymal transition prior to differentiation, it 
was important to exclude possible initiation of Hox6 expression in endocrine cells during 
the secondary transition. To test this, tamoxifen was administered to pregnant dams at 
E12.5, E13.5, and E14.5 and embryos were examined at E15.5. We found no Cre 
activity in Ngn3+ endocrine progenitors (Fig. 2.8A), with the pan-endocrine marker 
ChgA (Fig. 2.8B) or with epithelium (Fig. 2.8C). Similar results were obtained with 
tamoxifen administration daily from E10.5 to E17.5. There was no overlap of tdTomato 
with ChgA-positive endocrine cells, pancreatic epithelium, endothelial, neuronal or 
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smooth muscle cells (Fig. 2.7D and Fig. 2.8D, E).  We observed extensive and 
complete co-labeling of tdTomato and Vmtn-positive mesenchyme (Fig. 2.7D), 
confirming Hox6 expression is exclusive to the pancreatic mesoderm-derived 
mesenchyme.  
 
Vasculature is normal in the Hox6 null pancreas 
It has been previously reported that hyper-vascularization affects pancreas 
organogenesis by reducing branching and differentiation of epithelial cells, and signals 
from the vasculature are also important for the proper formation of endocrine cells of the 
pancreas (Lammert et al., 2001; Magenheim et al., 2011). Immunofluorescence staining 
for PECAM at E14.5 (Fig. 2.9A) and E18.5 (Fig. 2.9B) reveals no difference in 
vasculature between the control and mutant pancreas. There are also no differences in 
the association of endothelial and insulin-positive endocrine cells between control and 
Hox6 null E18.5 pancreas (Fig. 2.9C). 
 
Wnt signaling is disrupted in the mesoderm and differentiating endocrine cells in 
Hox6 mutant pancreata  
Microarray analysis was performed on E12.5 control and Hox6 mutant pancreata 
to probe for the molecular mechanism(s) responsible for the Hox6 mutant phenotypes 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68390). ToppFun 
(https://toppgene.cchmc.org/enrichment.jsp) analysis identified changes in members of 
the Wnt receptor-signaling pathway as significantly enriched in the Hox6 mutant 
pancreas, but no significant changes in other major signaling pathways.  
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To confirm our microarray results, we used qRT-PCR analysis to measure the 
expression levels of genes from major signaling pathways with reported or measured 
expression in the pancreas. No changes in the levels of Fgf, Bmp or Notch pathway 
members were measured in E12.5 mutant pancreata (Fig. 2.10A). There were also no 
differences in the measured expression of Wnt receptors between control and Hox6 
mutant pancreata (Fig. 2.10B). There are no differences in expression of Wnt2b, Wnt4, 
Wnt7b, or Wnt11, other Wnt ligands expressed in pancreas at E12.5, between mutant 
and control pancreata (Fig. 2.10B)(Heller et al., 2002), and we were unable to detect 
expression of Wnt1 and Wnt8b, genes reported to be expressed in the mesenchyme 
later in development, in either the control or Hox6 mutant pancreas at E12.5 (data not 
shown) (Heller et al., 2002). However, we observed significantly reduced expression 
levels of mesodermally expressed Wnt ligand, Wnt5a, at both E12.5 and E14.5 (Figs. 
2.10B,C).  
Hox6 genes are expressed solely in the mesoderm and therefore we examined 
mesodermally expressed Wnt genes as possible direct targets of Hox6. Wnt5a is 
expressed in both the pancreas epithelium and mesenchyme (Heller et al., 2002). In situ 
hybridization analyses of Wnt5a revealed much weaker expression in the Hox6 mutant 
pancreas mesenchyme at E12.5 compared to controls (Fig. 2.10D). At E14.5, reduced 
Wnt5a expression is even more apparent in the Hox6 mutant pancreas mesenchyme 
compared to controls, while expression in the epithelium appears identical (Fig. 2.10E). 
At E14.5 and beyond, we measure a significant reduction of more Wnt receptors and 
ligands as well, suggesting a secondary perturbation of Wnt signaling more globally in 
the Hox6 mutant pancreas at later stages (Fig. 2.10C). Wnt2b, Wnt4, Wnt7b and Wnt11 
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were also examined by ISH however, no obvious changes in expression pattern were 
detected between the control and Hox6 mutant pancreas (Fig. 2.11A-D).  
We reasoned that this disruption in Wnt signaling in the mesoderm might lead 
directly to changes in the Ngn3-expressing endocrine precursors after delamination 
from the ductal epithelium. The expression of a number of Wnt inhibitors has been 
reported in the pancreas epithelium and in endocrine cells throughout development 
including Sfrp1-4, Dkk1-3, and Wif1 (Heller et al., 2002; Gu et al., 2004). Of the Wnt 
inhibitors examined in the pancreas just two, Sfrp3 and Dkk1, showed significantly 
reduced expression levels in the Hox6 mutant at E12.5 (Fig. 2.12A). Using 
immunofluorescent staining with antibodies to Sfrp3 and Dkk1, we observe extensive 
overlap of Sfrp3 and Dkk1 with endocrine cells in wild-type pancreata (Fig. 2.12B). 
Overall, Hox6 mutant pancreata exhibited drastically reduced levels of Sfrp3 and Dkk1 
(Fig. 2.12C, D). Close examination reveals co-localization of Sfrp3 and Dkk1 in a subset 
of Ngn3+ endocrine progenitor cells in the control and none in the Hox6 mutant 
pancreas (Fig. 2.12E, F). This reduction of Wnt inhibitors continues through later stages 
of pancreas development (Fig. 2.13).  
Wnt5a is the first mesodermally expressed Wnt ligand with disrupted expression 
in the Hox6 mutant pancreas. If the lack of endocrine cell differentiation in the Hox6 
mutant pancreas stems from the lack of a sufficient amount of Wnt5a signaling from the 
mesoderm, we reasoned that it might be possible to rescue this phenotype with the 
addition of exogenous Wnt5a to the Hox6 mutant pancreata. To test this, we dissected 
control and Hox6 mutant pancreata at E12.5 and cultured them for six days in the 
presence and absence of exogenous Wnt5a (Fig 2.14A). Without exogenous Wnt5a in 
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the culture, we observed significant reduction of mature endocrine cells in the Hox6 
mutant pancreata compared to controls, similar to the in vivo phenotype (Fig. 2.14B and 
C). When recombinant Wnt5a protein was added to the culture media of Hox6 mutant 
pancreata, the quantity of mature endocrine hormone staining was rescued to the same 
level as control pancreata (Fig. 2.14B and C).  
 
Discussion 
 While the importance of the mesenchyme in pancreas development was 
demonstrated decades ago, the molecular mechanisms involved in the crosstalk 
between the epithelium and the mesenchyme are poorly understood. Here we report a 
novel role for Hox6 genes in pancreas development as diagrammed in the model in 
Figure 2.18. Loss of Hox6 function in the pancreatic mesoderm leads to mild defects in 
branching and delayed exocrine cell differentiation however, the pancreas achieves its 
normal size by newborn stages with extensive acinar cell formation. Endocrine cells are 
specified normally, but immature endocrine cells do not mature, resulting in a dramatic 
reduction of all types of fully differentiated endocrine cells, including >90% decreases in 
insulin and glucagon expression. 
Specific components of the Wnt signaling pathway are disrupted by E12.5 while 
no changes in other critical developmental signaling pathways, including Fgf, Bmp, and 
Notch, are observed. Mesenchymal ligand expression of Wnt5a is significantly down-
regulated (or absent) while epithelial expression of this ligand appears unperturbed. 
Wnt5a is expressed from E11 to the end of gestation with peak levels of expression at 
E12, similar to our measured Hox6 gene expression profile (Heller et al., 2002). A study 
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examining MO knock-down of Wnt5a and Fz-2 in zebrafish and global loss-of-function 
of Wnt5a in mice reported defects in islet formation in both organisms (Kim et al., 2005), 
consistent with loss of Wnt5a expression in the mesoderm contributing to the endocrine 
phenotype in our Hox6 mutant animals. 
In addition to loss of Wnt5a signaling in the pancreatic mesoderm, which may 
result directly from loss of Hox6 function, there is a subsequent loss of expression of 
Wnt inhibitors, Sfrp3 and Dkk1, specifically in delaminated Ngn3+ endocrine precursor 
cells as they are entering the mesoderm. As previous studies have demonstrated the 
importance of repressing Wnt signaling in developing endocrine cells (Pedersen and 
Heller, 2005), it is likely that loss of Wnt inhibitor induction in Ngn3+ progenitors leads 
directly to loss of further endocrine cell differentiation in Hox6 mutant pancreata. 
Pharmacological treatment of Hox6 mutant pancreata with exogenous Wnt5a protein is 
sufficient to restore endocrine cell differentiation, and demonstrates that Wnt5a is a 
critical mediator downstream of Hox6 genes in the pancreatic mesenchyme during 
development. Collectively, our results suggest that Hox6 genes are critical for the 
establishment of the Wnt mesenchymal-epithelial crosstalk necessary for pancreas 
development and endocrine cell specification. 
 Hox genes are important for many aspects of development and organogenesis, 
but no disruption of Hox function has previously been implicated in pancreas 
development. This work contributes to the growing understanding of pancreatic 
mesoderm signaling and the important roles the mesoderm plays in the development of 
both the endocrine and exocrine components of the pancreas. Here we show a direct 
link between Hox function and Wnt signaling; a theme that is reminiscent to a recent 
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report of loss of Wnt2/2b expression in the mesenchyme of Hox5 triple mutant lungs 
during development (Hrycaj et al., 2015). Another recent study examining Hoxd13 
function in digit development reports that Hoxd13 promotes expression of Wnt5a in vitro 
(Kuss et al., 2014). All Hox proteins bind to the same –ATTA- binding sequence and 
therefore it is plausible that Wnt5a is a direct target of Hox proteins during development. 
Future work will be required to establish possible direct regulation of Wnt5a by Hox6.  
This study adds to growing evidence that Hox function in the mesoderm of 
several organ systems plays region-specific roles associated with the establishment of 
proper Wnt signaling crosstalk during organogenesis (Kuss et al., 2014; Hrycaj et al., 
2015). A more complete elucidation of mesodermal-endodermal crosstalk during 
pancreas development is critical to the enhancement of ex vivo protocols for generating 
functional beta cells as a cellular therapy for the treatment of diabetes.  
 
Materials and Methods 
Generation of mouse mutants 
Mice mutant for all three Hox6 paralogous genes were generated using standard 
genetic crosses (Kostic and Capecchi, 1994; Rancourt et al., 1995; Garcia-Gasca and 
Spyropoulos, 2000). Hoxb6CreERT mice were contributed by Dr. Susan Mackem 
(Nguyen et al., 2009). R26Tom mice were obtained from The Jackson laboratory 
(Madisen et al., 2010). All experiments were performed following protocols approved by 
the University of Michigan’s Institutional Committee on the Use and Care of Animals. 
 
Tamoxifen injections 
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 Tamoxifen and progesterone were dissolved in 100% ethanol and diluted in corn 
oil. Pregnant dams were given intraperitoneal injections with 1.5 mg of tamoxifen and 
0.75 mg of progesterone on the days noted in Results.  
 
In situ hybridization 
 For section in situ hybridization (ISH), embryos were collected in PBS and fixed 
overnight in 4% paraformaldehyde in PBS at 4°C. Embryos were then rinsed in PBS 
and immersed in 30% sucrose at 4°C overnight before embedding into optimal cutting 
temperature (OCT) media. Frozen sections 20 µm in size were cut, and slides were 
stored at −80°C.  Section ISH was performed as previously described (Mendelsohn et 
al., 1999; Di Giacomo et al., 2006). Detection of Hox6 mRNA was done using probes 
generated against the 3’ UTR of Hoxa6, Hoxb6, and Hoxc6 or against the Neor cassette 
as previously described and with indistinguishable results from probes against Hox6 
gene mRNA (McIntyre et al., 2007). Wnt5a cDNA was ligated into PCR4-TOPO vector 
and reverse transcribed with T3 RNA polymerase. Sequenced plasmid aligns to mouse 
Wnt5a: GeneBank gi 46909566/NM 009524.2 from bp 406 to 1440. Wnt2b, Wnt4, 
Wnt7b and Wnt11 ISH was performed with previously published riboprobes (Miller et al., 
2012; Soofi et al., 2012; Ranghini and Dressler, 2015). 
 
Immunofluorescent Staining  
 Mouse embryos were collected as described above. Frozen sections 12 µm in 
size were cut, and slides were stored at −80°C. Slides were blocked for one hour at 
room temperature in 0.1% or 0.5% Triton X-100 in PBS (PBS-T) with 1% donkey serum 
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and treated with primary antibody overnight at 4°C. On day two slides were washed in 
PBS-T, incubated with secondary antibody for two hours at room temperature, followed 
by a 10-minute wash in PBS-T with DAPI (Sigma Aldrich). Coverslips were added to the 
slides using Prolong Gold Antifade Reagent (Invitrogen). Primary and secondary 
antibodies used are listed in Table 2.1. Slides were imaged using either an Olympus 
BX-51 or Leica SP5X 2-Photon Confocal. 
 
Whole mount Muc-1 staining 
 Tissue was fixed in 4% PFA for three hours at 4°C, dehydrated in MeOH and 
stored at  
-20°C until stained. Fixed tissue was treated with Dent’s bleach (MeOH: DMSO: H2O2, 
4:1:1) for 2 hours at room temp, blocked with TNB (Perkin Elmer) and incubated 
overnight with anti-Muc-1 antibody in TNB at 4°C. Pancreata were then washed with 
PBS and incubated with secondary antibody in TNB overnight at 4°C. Pancreata were 
imaged in BABB (benzyl alcohol: benzyl benzoate, 1:2) on a Leica SP5X Inverted 2-
Photon FLIM Confocal. Confocal Z-stacks were reconstructed using ImageJ. Antibodies 
are listed in Table 2.1. 
RNA Isolation and Quantitative RT-PCR  
 RNA was isolated from mouse pancreata with the Qiagen RNeasy Micro Kit.  
Quantitative RT-PCR (qRT-PCR) was carried out using Roche FastStart SYBR Green 
Master Mix and the Applied Biosystems StepOnePlus Real-time PCR system (Life 
Technologies). Relative expression values were calculated as 2−ΔΔCt and values of 
controls were normalized to 1. Rn18s served as an internal control for normalization in 
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all qRT-PCR experiments. All data are shown as the mean of at least three independent 
biological replicates; error bars represent s.e.m. Calculations and P-values (two-tailed, 
unpaired t-test) were generated in Microsoft Excel. Results were considered statistically 
significant at P < 0.05. Graphs were generated using Prism 6. Primer sequences are 
listed in Table 2.2.    
Pancreas explant cultures and rescue 
 Pancreata were dissected at E12.5 and cultured at the air-media interface on a 
Nucleopore Track-Etched Membrane (Whatman) in DMEM / F12 with L-Glutamine and 
15mM HEPES (Gibco) supplemented with Pen/Strep (Gibco). For rescue, the media 
was supplemented with 500ng/mL Recombinant Human/Mouse Wnt5a (R&D Systems) 
and refreshed with new media and Wnt5a protein on day two of culture. After six days in 
culture, pancreata were fixed at room temperature in 4% PFA for three hours, immersed 
in 30% sucrose at 4°C overnight and frozen in OCT the next day. Pancreas explants 
were cryosectioned at 12 µm and stained as described above for Ins/Gcg. ImageJ 
software was used to calculate the area of signal for DAPI and Ins/Gcg. Quantification is 
displayed as total Ins and Gcg signal / total DAPI signal for each explant.  
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Figure 2.1. Hox6 mutant embryos are externally indistinguishable from controls. 
(A) Dissected control and Hox6 mutant embryos at E18.5. (B) Embryos were weighed at 
E14.5 and E18.5. There is no change in embryos mass at E14.5 or E18.5 regardless of 
Hox6 mutation.  
 
 
 
 
 
 
 
 
 
	   46	  
 
 
Figure 2.2. Loss of Hox6 function results in abnormal pancreas morphology, but 
normal amylase expression. 
(A) E18.5 dissected pancreata from control and Hox6 aabbcc embryos. Hox6 null 
pancreata show abnormal pancreas morphology. Black arrowheads show compact 
ventral region of the pancreas in the mutant. Yellow arrowheads show narrower, more 
compact dorsal region with less lateral branching compared to controls. (B) 
Immunofluorescent staining for Amy (green) in sectioned E18.5 control and Hox6 
aabbcc pancreata shows normal amylase patterns.  
(C) Immunofluorescent staining for Ecad (green) shows that the epithelium of the Hox6 
null pancreas is more compact with less branching than the control pancreas at E14.5. 
(D) Whole mount immunofluorescence for Muc-1 (green) at E14.5 shows that the 
control has a well-defined multi-lumen plexus whereas the Hox6 null pancreas is less 
developed. Close up images show both ductal (red arrowheads) and tip (white 
arrowheads) regions are readily visible in the control pancreas however there are fewer 
ductal lumens apparent in Hox6 mutant. (E) Immunofluorescent staining for Sox9 
(green) and Cpa1 (red) shows no co-localization in control tip cells at E14.5 but many 
Cpa1/Sox9 double positive cells in the Hox6 null pancreas.  
(F) Immunofluorescent staining for Hnf1β (green) and Cpa1 (red) shows no co-
localization in control tip cells at E14.5 but Cpa1/Hnf1β double positive cells in the Hox6 
null pancreas. Arrowheads indicate double positive cells. Scale bars, 100 µM (B and C); 
50 µM (D); 20 µM (E); 15 µM (F).  
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Figure 2.3. Hox6 mutant pancreata have slightly reduced proliferation, but no 
overall changes in volume. 
(A-G) Epithelial volume by Pdx1 staining at E10.5 (B) and E11.5 (D) quantified relative 
to control (A). Every section was imaged and the area of Pdx1+ staining was calculated 
with ImageJ to measure total volume. Epithelium proliferation was measured by 
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counting the number of Phh3+Pdx1+ cells and dividing by the Pdx1 volume calculated 
in panel A. At E14.5 the number of Phh3 cells in the epithelium was divided by Ecad+ 
volume calculated similarly to Pdx1 volume (C and F). There are no significant changes 
in mesenchyme volume (E) or proliferation (G). (H) There are no changes in pancreas 
mass regardless of Hox6 mutation. Pancreata were weighed and divided by embryo 
mass. (I) Apoptosis was detected by antibody staining for CC3 at E18.5. There are no 
differences between control and mutant pancreata. Results are mean±s.e.m. *P<0.05 
calculated by Student’s t-test (n≥3). Scale bars, 100 µM in (B, D, F, and I). 
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Figure 2.4. Hox6 mutant pancreata demonstrate a drastic reduction of endocrine 
hormone expression. 
(A) Immunofluorescent staining for Ins (green), Gcg (Red) and nuclei (blue) was 
performed at E14.5. qRT-PCR shows reduced expression of all five endocrine cell 
hormones at E14.5 in the mutant pancreas. (B) Immunofluorescence shows decreased 
staining for Ins (green) and Gcg (red) in the mutant pancreas at E18.5. There is a 
dramatic reduction of all five endocrine cell hormones at E18.5 in the mutant. Results 
are mean±s.e.m. *P<0.05 calculated by Student’s t-test (n≥3). Scale bars, 100 µM (A 
and B).  
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Figure 2.5. Immature endocrine cell genes are decreased in the mutant but there 
is no defect in endocrine progenitor delamination. 
(A) Immunofluorescent staining for Ngn3 (green) and nuclei (blue) shows no change 
between control and Hox6 null pancreata at E14.5. (B-C) Immunofluorescent staining 
shows a decrease in signal of both Isl1 (B) and ChgA (C). (D) qRT-PCR analyses show 
no change in the expression of Ngn3, Nkx2.2, Nkx6.1 or Pax6, but there are 
significantly reduced levels of expression of MafA, MafB, NeuroD, Isl1, and ChgA in the 
Hox6 mutant pancreas at E14.5. (E) Immunofluorescent staining for Sox9 (red) and 
Ngn3 (green) at E14.5 in control and Hox6 aabbcc pancreata. Quantification of Sox9+ 
and Ngn3+ cells shows that 25% of Ngn3+ (white arrows) cells in both the control and 
Hox6 null pancreas are also Sox9+ (yellow arrows). Results are mean±s.e.m. *P<0.05 
calculated by Student’s t-test (n≥3). Scale bars, 100 µM (A-E). 
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Figure 2.6. Ngn3 is unchanged at E18.5. 
Immunofluorescence for Ngn3 shows no change between control and Hox6 mutant 
pancreata at E18.5. Scale bar, 100 µM. 
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Figure 2.7. Hox6 expression is limited to the pancreas mesenchyme. 
(A) qRT-PCR analysis shows expression of Hoxa6, b6, and c6 in the pancreas 
throughout gestation with expression of all three genes highest early in development. 
No expression above the limit of detection was measured for any of the three Hox6 
genes at E18.5. Values are relative to the colon where there is a low level of Hox6 
expression. (B) ISH shows combined Hox6 gene expression in the mesenchyme at 
E11.5 and E12.5. (C) Hoxb6CreERT and Rosa26-tdTomato mice were crossed and 
tamoxifen was administered to pregnant dams via IP injection at E9.5 and E10.5 to 
examine reporter expression in the pancreas. Cre activity (red) was detected at an 
anterior limit in the lateral plate mesenchyme at the level of forelimb; the anterior limit in 
the somatoplueric mesenchyme is at the level of the pancreatic buds. The dorsal 
pancreas (dp) and ventral pancreas (vp) exhibits strong td-tomato (red) signal 
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throughout the mesenchyme. Epithelium is stained with Ecad (green). Cre activity is 
also excluded from Ins+ cells, Pdx1+ cells, and PECAM+ endothelium in the pancreas. 
(D) Daily tamoxifen administration to pregnant dams via IP injection from E10.5 to E17.5 
shows reporter expression excluded from ChgA+ endocrine cells, Ecad+ epithelial cells, 
and PECAM+ endothelial cells in Hoxb6CreERT;Rosa26-tdTomato embryos. Cre 
activity is detected throughout the pancreas mesenchyme as co-labeled with Vmtn. 
Scale bars, 100 µM (B-D). Results are mean±s.e.m (n≥3). 
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Figure 2.8. Hox6 gene expression is restricted to the mesenchyme. 
(A-C) Tamoxifen was injected at E12.5, E13.5, and E14.5. At E15.5 td-tomato (red) is 
excluded from Ngn3+ endocrine progenitor cells (A), ChgA+ endocrine cells (B) and the 
epithelium (C). To assess if Hox6 expression could be detected in neurons or smooth 
muscle, tamoxifen was injected daily from E10.5 to E17.5 and embryos were analyzed 
at E18.5. There is no Cre recombination in Tuj1+ neurons (D) or αSMA+ smooth muscle 
(E). Scale bars, 100 µM (A-E). 
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Figure 2.9. There is no change in vascularization in the Hox6 null pancreas.  
(A-B) Immunofluorescent staining for PECAM at E14.5 (A) and E18.5 (B) shows no 
change between the control and Hox6 null pancreas. (C) Immunofluorescent analysis 
shows Ins+ cells are closely associated with PECAM+ endothelial cells in both the 
control and Hox6 null pancreas. Scale bars, 100 µM (A); 200 µM (B and C).  
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Figure 2.10. Expression of Wnt5a and Wnt inhibitors Sfrp3 and Dkk1 is lost in the 
Hox6 mutant pancreas. 
(A) qRT-PCR analysis of genes from the Fgf, Bmp, and Notch pathways at E12.5. (B-C) 
qRT-PCR analysis of Wnt receptor and ligand expression at E12.5 (B) and E14.5 (C). 
(D) ISH at E12.5 using probe for Wnt5a shows staining throughout the pancreas and a 
significant reduction of signal in the Hox6 mutant pancreas. (E) At E14.5, Wnt5a is 
expressed in both the mesenchyme and epithelium of control pancreata. Wnt5a 
expression in the Hox6 null pancreatic mesenchyme (M) is lost, but epithelial 
expression appears normal. Scale bars, 100 µM (D-E). Results are mean±s.e.m. 
*P<0.05 calculated by Student’s t-test (n≥3).  
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Figure 2.11. Expression of Wnt2b, Wnt4, Wnt7b, and Wnt11 appears similar 
between control and Hox6 mutant pancreata. 
(A-D) At E12.5 the expression of Wnt7b is epithelial in the developing pancreas and 
there is no difference between control and mutant pancreas (A) as shown by ISH. (B) 
ISH at E14.5 for Wnt2b does not show differences in expression pattern between 
control and Hox6 mutants. There was very little signal for expression of Wnt4 (C) and 
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Wnt11 (D) in the developing pancreas by ISH despite very strong signal in the kidney on 
the same or adjacent sections. Scale bars, 100 µM (A-D). 
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Figure 2.12. Expression Wnt inhibitors Sfrp3 and Dkk1 is lost in endocrine 
progenitors in the Hox6 mutant pancreas. 
(A) qRT-PCR analysis of Wnt inhibitors in control and Hox6 mutant pancreata at E12.5.  
(B) Immunofluorescent staining for Wnt inhibitors Sfrp3 (green) and Dkk1 (green) with 
endocrine markers ChgA (red) and a combination of antibodies for Ins and Gcg (red) 
shows consistent overlap of staining in E13.5 mouse pancreas. (C-D) 
Immunofluorescent staining for Sfrp3 (C) and Dkk1 (D) in control and Hox6 aabbcc 
pancreata. There is a drastic reduction of signal for both Wnt inhibitors in the mutant 
pancreas at E12.5. (E-F) Sfrp3 (E, green), Dkk1 (F, green) and Ngn3 (E and F, red) in 
control and Hox6 mutant pancreata at E12.5. Signal for Sfrp3 and Dkk1 is absent in 
Ngn3+ endocrine progenitor cells in Hox6 mutant pancreata. Scale bars, 100 µM (C and 
D) and 25 µM (B, E and F). Results are mean±s.e.m. *P<0.05 calculated by Student’s t-
test (n≥3).  
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Figure 2.13. Wnt inhibitor expression is reduced in the Hox6 mutant pancreas. 
qRT-PCR analysis at E14.5 between control and Hox6 mutant pancreata shows a 
significant decrease in expression of all Wnt inhibitor genes examined. Results are 
mean±s.e.m. *P<0.05 calculated by Student’s t-test (n≥3). 
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Figure 2.14. Exogenous Wnt5a treatment rescues endocrine cell differentiation in 
Hox6 mutant pancreas. 
(A) Control and Hox6 mutant pancreata were dissected at E12.5 and cultured for six 
days in media with and without recombinant Wnt5a protein. On day two of culture, fresh 
media with or without Wnt5a was added to the explants. (B) Immunofluorescent staining 
for combination of Ins and Gcg primary antibodies on pancreas explants collected after 
six days in culture. (C) Quantification of immunofluorescent staining using ImageJ 
software shows that untreated Hox6 mutant pancreata have significantly less endocrine 
staining per total DAPI area than control pancreata. Hox6 mutant pancreata treated with 
Wnt5a protein have the same amount of endocrine staining per DAPI area as controls. 
n=3 for each condition/genotype. Scale bar is 100 µM (B). Results are mean±s.e.m. P 
values were calculated by Student’s t-test. 
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Figure 2.15. Hox6 regulates mesenchymal Wnt5a expression to promote 
endocrine cell differentiation. 
Mesenchymal Hox6 promotes the expression of Wnt5a in the mesenchyme, which 
signals to endocrine precursor cells to initiate expression of Sfrp3 and Dkk1 to allow 
differentiation to more mature, hormone producing endocrine cells. When Hox6 function 
is disrupted, expression of Wnt5a, Sfrp3, and Dkk1 is lost and differentiation of mature 
endocrine cells is inhibited in the Hox6 mutant pancreas. 
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Table 2.1. List of primary and secondary antibodies 
 
Antibody Dilution Vendor Catalog 
Number 
Rabbit anti-Amy 
Guinea pig anti-Ins 
Guinea pig anti-Pdx1 
Armenian hamster anti-PECAM 
Goat anti-Ngn3 
Goat anti-ChgA 
Mouse anti-Vmtn 
Rabbit anti-Cpa1 
 
Goat anti-Hnf1β 
Rabbit anti-Gcg 
Goat anti-Isl1 
Rabbit anti-Sox9 
Goat anti-Ecad 
Rabbit anti-Sfrp3/Frzb 
Hamster anti-Muc1 
Rabbit anti-Cleaved Caspase-3 
Mouse anti-Tuj1 
Rabbit anti-αSMA 
Alexa Fluor 488 anti-goat 
 
Cy3 anti-goat 
 
Cy3 anti-rabbit 
 
DyLight 488 anti-guinea pig 
 
Alexa Fluor 488 anti-Armenian  
hamster 
AlexaFluor 488 anti-rabbit 
AlexaFluor 488 anti-mouse 
1:100 
1:500 
1:500 
1:50 
1:100 
1:100 
1:200 
1:100 
 
1:100 
1:100 
1:100 
1:500 
1:500 
1:100 
1:200 
1:100 
1:500 
1:100 
1:500 
 
1:500 
 
1:500 
 
1:500 
 
1:500 
 
1:500 
1:500 
Sigma Aldrich 
Dako 
Abcam 
DSHB 
Santa Cruz 
Santa Cruz 
Sigma Aldrich 
Rockland 
Immunochemicals 
Santa Cruz 
Millipore 
R&D Systems 
Millipore 
R&D Systems 
Genway 
NeoMarkers 
Cell Signaling 
Promega 
Abcam 
Jackson  
Immunoresearch 
Jackson  
Immunoresearch 
Jackson  
Immunoresearch 
Jackson  
Immunoresearch 
Jackson 
Immunoresearch 
Invitrogen 
Invitrogen 
090M4801 
A0564 
AB47308 
AB_2161039 
sc-13793 
sc-1488 
091M4791 
100-4152 
 
sc-7411 
AB932 
AF1837 
AB5535 
AF748 
GWB-MT441I 
HM-1630-P 
9661 
G7121 
AB5694 
705-545-003 
 
705-165-003 
 
711-165-152 
 
706-545-148 
 
127-545-160 
 
A21206 
A31570 
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Table 2.2. List of qRT-PCR primers for embryonic tissue 
 
Target Forward Primer Reverse Primer 
Bmp2 
Bmp4 
Bmp5 
Bmp7 
Bmper 
ChgA 
Dkk1 
Dkk2 
Dkk3 
Dll1 
Dll3 
Fgf9 
Fgf10 
Fzd2 
Fzd3 
Fzd4 
Fzd5 
Fzd6 
Fzd8 
Gcg 
Ghr 
Hes1 
Hey2 
Hoxa6 
Hoxb6 
Hoxc6 
Ins 
Isl1 
MafA 
MafB 
NeuroD 
Ngn3 
Nkx2.2 
Nkx6.1 
Notch1 
Notch2 
Pax6 
Pp 
Sfrp1 
Sfrp2 
Sfrp3 
Sfrp4 
AGACCACCGGCTGGAGAG 
TGGACTGTTATTATGCCTTGTTT 
CATGGTCATGAGCTTTGTCA 
TGGTCATGAGCTTCGTCAAC 
TCCAGACCTGCCACTCTACA 
ATGACAAAAGGGGACACCAA 
ATGAGGCACGCTATGTGCT 
CTCAGTCAGCCAACCGATCT 
CCAGAGTGGACAGGTGGTCT 
GGAGAAGATGTGCGACCCT 
TCCCTGTCTCCACCAGTAGC 
ACGAGAAGGGGGAGCTGTAT 
GCAACAACTCCGATTTCCAC 
ACATCGCCTACAACCAGACC 
CATCTGGGAGACAACATGGA 
TGCAGCTGACAACTTTCACG 
TTGTCGTTAAACTTTCCCAGC 
ATTATGACCAGGGGATCGCT 
TCCGTTCAGTCATCAAGCAG 
ACTCCCGCCGTGCCCAAGAT 
ACCCAGAGGACAGAGGACAA 
GGCAGACATTCTGGAAATGA 
TGAAGATGCTCCAGGCTACA 
GTCTGGTAGCGCGTGTAGGT 
GAGACCGAGGAGCAGAAGTG 
CAGGGTCTGGTACCGAGAGTA 
CAAACAGCAAAGTCCAGGGGGC 
GGTTAGGGATGGGAAAACCT 
GAGGAGGTCATCCGACTGAA 
TCCACCTCTTGCTACGTGTG 
ACGCAGAAGGCAAGGTGTC 
ACCCTATCCACTGCTGCTTG 
CCGAGGGCCTCCAATACT 
GGATGACGGAGAGTCAGGTC 
GAATGGAGGTAGGTGCGAAG 
TGCTGTGGCTCTGGCTGT 
CGGGACTTCAGTACCAGGG 
CTGGGCCCAACACTCACTA 
CATCTCTGTGCAAGCGAGTT 
CGACATCATGGAAACCCTTT 
AGTACTGGACACTGCAGAGGG 
TCGAACACAAGTCCCTCTCA 
TTTCCCACTCATCTCTGGAA 
ATCAAACTAGCATGGCTCGC 
CTCCATGTGGAATCTGGGTC 
TGGAAAGATCAAACCGGAAC 
CGCCAGAAATGACTCACAGTA 
GTCTCCAGACACTCAGGGCT 
ATGCTTTCCTCAATTTCCCC  
ATCACTGCTGCAAGGGTAGG 
GGCCCACAGTCTTCATCAAT 
CTCCCCTGGTTTGTCACAGT 
GTTCCCATCACAAGGTCCAG 
AGAGGTTGGAAGAGTAGGTGTTG 
GATTGAGAAGAACGGCAAGG 
CACCAGCGGGTAGAACTGAT 
GAATCAGGTCTGGACGACTCA 
TCTTCTCTGTGCACATTGGC 
CTCCGACTCCAAGGACAGAA 
AAAAGCTTGGCAAAGGAACA 
CGTGTAGAGCACGGTGAAGA 
AGGAGCCATCAGCGTGCCTG 
CTGAGCTCCTGACAGCTTGA 
GGTATTTCCCCAACACGCT 
TCTGTCAAGCACTCTCGGAA 
CCCTGTTTACCCCTGGATG 
CAGGGTCTGGTAGCGTGTG 
TCCAGATTTACCCCTGGATG 
TCCACTTCACGGCGGGACTTG 
CACGAAGTCGTTCTTGCTGA 
TTCTCGCTCTCCAGAATGTG 
CGTTAGTTGCCAATGTGTGG 
CGCTCTCGCTGTATGATTTG 
AGGTTGTTGTGTCTCTGGGG 
TTGTCATTGTCCGGTGACTC 
CGAGTCCTGCTTCTTCTTGG 
CTGAGGCAAGGATTGGAGTC 
TGTGCCGTTGTGGTAGGTAA 
CTTCATCCGAGTCTTCTCCG 
CAGAGCCACCCAAGTGGATA 
GGGTTTCTTCTTCTTGGGGA 
TTGCTCTTTGTCTCCAGGATG 
AGCCCGGATGACATAGTTGT 
ATCATCCTTGAACGCCACTC 
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Sst 
Wif 
Wnt1 
Wnt2b 
Wnt4 
Wnt5a 
Wnt7b 
Wnt8b 
Wnt11 
 
CAGACTCCGTCAGTTTCTGC 
CCATCAGGCTAGAGTGCTCA 
AAATGGCAATTCCGAAACC 
CTGCTGCTGCTACTCCTGACT 
CCTGCGACTCCTCGTCTTC 
ACGCTTCGCTTGAATTCCT 
ACGTGTTTCTCTGCTTTGGC 
CCCGTGTGCGTTCTTCTAGT 
CTGCGAGGCTCTGCTCTTT 
TTCTCTGTCTGGTTGGGCTC 
GCATTCTTTGTTGGGCTTTC 
GAAGATGAACGCTGTTTCTCG 
GGGGATGTTGTCACAGATCA 
GTTTCTCGCACGTCTCCTCT 
CCGGGCTTAATATTCCAATG 
CCAGGCCAGGAATCTTGTT 
AGACCAGGTAAGCCTTTGGA 
TCTGATTCAGTGCCAAGGCT 
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CHAPTER 3 
 
HOX6 FUNCTION IN THE IN VITRO DIFFERENTIATION OF MESCS TO INSULIN-
PRODUCING CELLS 
 
 
Summary 
 
 The differentiation of glucose-responsive, insulin-producing cells from ESCs in 
vitro is promising as a cellular therapy for the treatment of diabetes, a devastating and 
common disease. Pancreatic β-cells are derived from the endoderm in vivo and 
therefore most current protocols attempt to generate a pure population of first 
endoderm, then pancreas epithelium, and finally insulin-producing cells. Despite this, 
differentiation protocols result in mixed populations of cells that are often poorly defined, 
but also contain mesoderm. Here, we describe a mouse ESC differentiation method that 
results in endoderm derived insulin-producing cells, as well as mesoderm with an 
appropriate region-specific Hox gene expression profile. Loss of function of all three 
Hox6 genes impairs the ability of mESCs to differentiate to insulin-producing cells in 
vitro as we have observed previously in vivo. Together, we describe a method to 
generate pancreatic endoderm and mesoderm in mouse ESCs, and we show that 
mesenchyme-specific perturbations in pancreas development in vivo are recapitulated 
in vitro using this model. This system will be useful for elucidating mechanisms involved 
in mesodermal support of pancreatic endoderm and insulin-producing cells.  
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Introduction 
 
 Diabetes affects more than 25 million Americans and over 300 million people 
worldwide (Pagliuca and Melton, 2013). The cause of Type 1 diabetes is the 
autoimmune destruction of insulin-producing pancreatic β-cells (Abdelalim and Emara, 
2015). Two major treatments for Type 1 diabetes include the maintenance of blood 
sugar levels by injection of exogenous insulin throughout each day and/or the 
transplantation of cadaveric insulin-producing β-cells (Shapiro et al., 2000; Pagliuca et 
al., 2014). There are inherent problems with these treatments including the 
invasiveness of constant injections, problems with improper management of blood 
glucose levels, the current lack of cadaveric β-cells, potential graft versus host disease 
and long-term immunosuppression (Russ et al., 2015). A promising treatment for 
diabetes is the generation of glucose-responsive, insulin-producing cells from human 
embryonic stem cells (hESCs) and/or induced pluripotent stem cells (iPSCs). This could 
alleviate the need for exogenous insulin injections and cadaveric β-cells (Pagliuca and 
Melton, 2013).  
 The pancreas is composed of exocrine and endocrine components. Exocrine 
cells secrete digestive enzymes into the small intestine to assist in nutrient metabolism. 
There are five types of endocrine cells that each secretes a separate endocrine 
hormone. Insulin-producing β-cells are one of the five distinct endocrine cells in the 
pancreas. All exocrine and endocrine cells of the pancreas arise from the foregut 
endoderm of the embryo (Gittes, 2009; Puri and Hebrok, 2010). While all of the major 
functional components of the pancreas are derived from the endoderm, the surrounding 
mesodermally-derived mesenchyme is critical for the growth and development of these 
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cell types (Golosow and Grobstein, 1962; Gittes et al., 1996; Miralles et al., 1998; 
Bhushan et al., 2001; Attali et al., 2007; Gittes, 2009; Puri and Hebrok, 2010). Explant 
studies were first used to demonstrate the importance of the mesenchyme. When 
pancreas epithelium is cultured in the absence of its surrounding mesenchyme, both 
endocrine and exocrine development is arrested with defects in growth and 
differentiation. These defects can be rescued by recombination with pancreatic and 
other types of mesenchyme (Golosow and Grobstein, 1962; Wessells and Cohen, 
1967). When the pancreas mesenchyme is genetically ablated in vivo, a similar failure 
in development of the exocrine and endocrine components results (Landsman et al., 
2011). Critical signals from the surrounding mesoderm that inform pancreas 
specification and development include fibroblast growth factor (FGF), bone 
morphogenetic protein (Bmp), and retinoic acid (RA) (Bhushan et al., 2001; Stafford and 
Prince, 2002; Martin et al., 2005; Molotkov et al., 2005; D'Amour et al., 2006; Nostro et 
al., 2011). Moreover, co-culture with pancreatic mesenchyme significantly expands 
pancreatic progenitor cell populations in vitro, indicating that mesenchyme may be 
critical for generating the large number of cells needed for cell replacement therapy 
(Sneddon et al., 2012). While the role of mesenchymal to epithelial crosstalk has long 
been appreciated and some of the signaling mechanisms have been described, the 
mesenchymal signals required for differentiation of pancreatic endocrine cells are still 
not fully understood.  
Recently, we described a critical role for Hox6 gene function in the pancreatic 
mesenchyme for the proper differentiation of all five endocrine cell types (Larsen et al., 
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2015).  The Hox6 paralogous group is composed of three genes; Hoxa6, Hoxb6 and 
Hoxc6. In the pancreas, Hox6 genes are expressed only in the mesenchyme.  
Based on our recent in vivo data, we hypothesized that Hox6 genes also play a 
role in endocrine cell differentiation in vitro. We further hypothesized that enhancing 
mesodermal differentiation during in vitro pancreas differentiation would lead to an 
increase in efficiency of endocrine cell differentiation. Here, we modified existing 
protocols (D'Amour et al., 2006; Kroon et al., 2008) and developed a method to direct 
differentiation of mESCs into pancreatic endoderm and mesoderm. We also show that 
Hox genes normally expressed in the pancreatic region in vivo are also expressed in 
vitro, indicating that both pancreatic endoderm and mesoderm are differentiating and 
obtain the proper regional identity. In contrast, the most anterior and posteriorly 
expressed Hox genes are not present in vitro. In addition, we derived several Hox6 
triple-null mESC lines, along with controls, and show that Hox6 mutant mESCs have a 
decreased capacity for differentiation into insulin-producing cells in vitro compared to 
wild-type mESCs. Taken together, we show a critical role for mesodermally expressed 
Hox6 genes in the differentiation of endodermally derived insulin-producing cells in vitro.  
 
Results 
Differentiation of mESCs using three-dimensional culture 
 In order to stimulate cell-cell interactions and multi-lineage differentiation, our 
differentiation method utilized the hanging drop technique to first form embryoid bodies 
(EBs), followed by the implementation of a directed differentiation protocol that has 
been used in monolayer cultures for directed differentiation of human ESCs (D'Amour et 
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al., 2006; Kroon et al., 2008)(Figure 3.1). Briefly, after two days in hanging drop 
suspensions, EBs were embedded in a droplet of Matrigel in order to provide the cells 
with a supportive matrix in which to grow and maintain their three-dimensional structure. 
The EBs were then differentiated to definitive endoderm by treatment with 100ng/mL 
Activin A for four days. Following Activin A, EBs were analyzed for endodermal and 
mesodermal markers. Compared to mESCs, Activin A treated cells show significantly 
increased mRNA expression and protein levels of the endoderm markers Foxa2 (Fig. 
3.2A) and Sox17 (Fig. 3.2B)(Ang and Rossant, 1994; Weinstein et al., 1994; Kanai-
Azuma et al., 2002). When treated with Activin A, EBs do not show an increased 
induction of mesenchyme when compared to mESCs based on mesoderm marker 
Vimentin (Vim) mRNA expression, however scattered Vim-positive cells were observed 
by protein staining (Fig. 3.2C).  
 Foregut and pancreas differentiation was further induced by treatment with 
retinoic acid (RA,10µM), the Hedgehog inhibitor SANT-2 (10µM), and bFGF (50ng/mL) 
(RSF media). After two days in RSF media, media was replaced and EBs were cultured 
in “basal media” (see Methods) without growth factors for up to three weeks (Fig. 3.1). 
Pdx1 is the first marker of pancreas differentiation and is expressed in the epithelium by 
E9.5 during mouse development. We detected Pdx1 protein and found a significant 
increase in expression of Pdx1 at three weeks post-treatment with RSF media when 
compared to EBs (Fig. 3.3A). Similarly, the endocrine hormone Insulin (Ins) is 
expressed after three weeks post-RSF treatment (Fig. 3.3B). We also detected C-
peptide immunostaining in these conditions, indicating that pro-insulin protein is being 
produced and cleaved (Fig. 3.3B). Pancreatic exocrine cells are also produced after 
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RSF treatment. We observe significant increases in mRNA expression and antibody 
staining of Amy2 and Cpa1 three weeks post-RSF treatment (Fig. 3.3C, D). In addition 
to pancreatic lineage markers, we interrogated our cultures to determine the presence 
of other endodermal lineages. We examined the thyroid marker Pax8, lung marker, 
Nkx2.1 and intestinal marker Cdx2 (Plachov et al., 1990; Kimura et al., 1996; Silberg et 
al., 2000). Of these lineages, we only detected an enrichment of Pax8 relative to EBs 
(Fig. 3.4).  
 
Hox6 genes are critical for the differentiation of insulin-producing cells in vitro 
We have recently shown that Hox6 genes are critical for the differentiation of β-
cells in the developing mouse pancreas in vivo (Larsen et al. 2015). We therefore 
sought to determine if mesenchymal factors such as Hox6 genes influence the 
differentiation of endocrine cells in vitro. To confirm that Hox genes were present in 
differentiated EBs, we performed qRT-PCR analyses for a series of Hox genes that are 
expressed at different levels along the anterior-posterior axis of the embryo in vivo (Fig. 
3.5). Examining several stages throughout the differentiation protocol (EB, Endoderm, 2 
weeks post RSF media, 3 weeks post RSF media), we observed that Hox gene 
expression in vitro mimics Hox gene expression at the level of the pancreas in the 
embryo (Fig. 3.5)(Larsen et al., 2015). In the pancreatic foregut region of the embryo, 
Hox5 and Hox6 genes are robustly expressed whereas Hox1 and Hox2 genes are 
expressed more anteriorly and Hox11 and Hox13 genes are expressed more posteriorly 
(Fig. 3.5)(Dressler and Gruss, 1989; Duboule and Dolle, 1989; Graham et al., 1989). 
We detected a significant enrichment of all Hox5 and Hox6 genes post-RSF media (at 2 
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and 3 weeks in culture) compared to EB and endoderm stages whereas Hox1, Hox2, 
Hox11, or Hox13 expression was not enriched at any stage (Fig. 3.5). Collectively, our 
data suggests that the induction protocol we have implemented successfully generated 
pancreatic endoderm (Fig. 3.3) and mesoderm with the appropriate region-specific Hox 
gene expression (Fig. 3.5) 
To investigate the role of Hox6 genes in differentiation of pancreatic insulin-
producing cells, we derived three lines of Hox6 mutant mESCs from previously 
described Hox6 mutant crosses (McIntyre et al., 2007). In Hox6 mutant mESC lines, we 
observed expression levels of endodermal genes Foxa2 and Sox17 similar to control 
mESC lines following Activin A treatment, indicating that endoderm induction is not 
impaired in these cells (Fig. 3.6A).  
Following endoderm induction, control and Hox6 mutant cells were cultured in 
RSF media followed by basal media (as in Figure 1). Cells were collected after three 
weeks and examined for expression of endocrine and exocrine pancreas genes. At 
three weeks post-RSF treatment we observed similar increases in expression of Pdx1 in 
control cells and in Hox6 mutant cells relative to the EB stage (Fig. 3.6B). However, Ins 
mRNA and protein expression is markedly decreased in the Hox6 mutant cells 
compared to controls (Fig. 3.6C). In contrast, exocrine genes Amy2 (Fig. 3.6D) and 
Cpa1 (Fig. 3.6E) were expressed at comparable levels in both control and Hox6 mutant 
cultures (Fig. 3.65E). Amy2- and Cpa1-positive staining appears to occur only on 
epithelial-like cells of these cultures as would be expected (Fig. 3.6D and E). These 
data show that Hox6 mutant mESCs are capable of differentiating to exocrine cells 
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competently but are defective in their ability to differentiate into insulin-producing cells. 
This is the same phenotype observed in Hox6 null embryos in vivo (Larsen et al., 2015). 
 
Increased mesoderm differentiation does not improve differentiation efficiency 
Our results (Fig. 3.6) suggest that genes expressed solely in the mesenchyme 
(Hox6 genes) have an influence on the ability of mESCs to differentiate to pancreatic 
endocrine cells in vitro. To test if increasing the population of mesoderm early in 
differentiation would be able to provide better support for endodermal progenitor cell 
differentiation to insulin-producing cells, we added Bmp4 to the media at the same time 
as Activin A. Bmp4 has been previously shown to enrich mesoderm differentiation 
(Purpura et al., 2008; Sakurai et al., 2009). The addition of Bmp4 does not significantly 
alter the differentiation of endodermal cells as shown by equivalent levels of expression 
of Foxa2 in cells treated with Activin A alone or with Activin A + Bmp4 (Fig. 3.7A). Cells 
treated with Bmp4 have significantly higher expression of Vim shown by qRT-PCR and 
antibody staining, indicating an increase in the amount of mesoderm generated (Fig. 
3.7B). The induction of Ins expression did not appear to be affected by increasing the 
mesodermal population early in development (Fig. 3.7C). The addition of Bmp4 
significantly increased the population of mesoderm early in differentiation, however; at 
two and three weeks after treatment with RSF media, the amount of mesenchyme is 
indistinguishable in cultures treated with Activin A alone, or with Activin A and Bmp4 
(Fig. 3.7D). Taken together our data supports a role for mesenchymal factors, 
specifically Hox6, in endocrine, but not exocrine pancreas development in vitro, similar 
to what is observed in vivo.  
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Discussion 
 Here, we use a three-dimensional method of mESC differentiation to pancreas 
cells, including insulin-producing cells. By mimicking in vivo processes of differentiation, 
we are able to produce cells of both the exocrine and endocrine pancreatic lineages. 
We also show that Hox genes, critically important developmental transcription factors, 
initiate the expression patterns expected for the AP position of the pancreas during this 
differentiation procedure. In vivo, we have shown that Hox6 genes are important for the 
differentiation of insulin-producing cells, but not exocrine cells (Larsen et al., 2015). This 
shows that previously unappreciated factors produced in the pancreatic mesenchyme, 
such as Hox6 genes, may be critical to improve the generation of functional pancreatic 
tissue in vitro. Further study of the effects of multiple tissue types, including the 
mesenchyme, on mESC differentiation may lead to increased functional pancreatic cells 
and more fully differentiated tissue in vitro.   
 Treating mESCs with Bmp4 to increase the amount of early mesenchyme 
induced during differentiation did not increase the efficiency of differentiation of insulin-
producing cells. While there was a significant increase in the amount of mesenchyme 
generated immediately following Bmp4 treatment, this early induction of mesenchymal 
differentiation was not maintained and was insufficient in improving mESC 
differentiation to pancreatic tissue or, specifically, insulin-producing cells. Replacing the 
mesenchyme with recombinant proteins produced by the pancreatic mesenchyme in 
vivo improves pancreas cell differentiation in vitro; however, currently unidentified 
factors produced in pancreatic mesenchyme are likely to be important for improved 
differentiation of completely functional insulin-producing cells in vitro.  
	   77	  
 In addition to generating glucose-responsive, insulin-producing cells to treat 
diabetes, in vitro engineering a pancreatic organ has many uses for drug development 
and disease modeling. In addition to diabetes, treatments for other devastating 
pancreatic diseases such as pancreatitis and pancreatic cancer can be studied through 
the use of functional pancreatic tissue in vitro. The presence of ductal and exocrine cells 
will be critical for the accuracy of diagnostics using engineered pancreatic tissue. The 
inclusion of mesenchyme and also endothelial cells will be needed to further improve a 
useful in vitro pancreatic model (Lammert et al., 2001; Sneddon et al., 2012). While 
there have recently been significant strides towards the generation of functional 
pancreatic cells in vitro for the treatment of human disease, there is still more 
knowledge to be gained from studying the effects of all pancreatic tissue types in in vitro 
differentiation strategies.  
 
Materials and Methods 
Derivation of mESCs 
Mice mutant for all three Hox6 paralogous genes were generated using standard 
genetic crosses (Kostic and Capecchi, 1994; Rancourt et al., 1995; Garcia-Gasca and 
Spyropoulos, 2000). All experiments were performed following protocols approved by 
the University of Michigan’s Institutional Committee on the Use and Care of Animals. 
 
Differentiation Protocol 
 mESCs were cultured in DMEM (Gibco) supplemented with LIF (Millipore), 15% 
FBS (Gibco), Pen/Strep (Gibco), Glutamax (Gibco), NEAA (Gibco), Sodium Pyruvate 
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(Gibco), and β-mercaptoethanol (Sigma) on gelatin coated tissue culture plates with 
mitotically inactivated MEFs in a 37ºC incubator with 5% CO2. EBs were formed by 
pipetting 2,000 mESCs in 20µl drops of culture media without LIF onto a tissue culture 
plate and suspended upside-down for two days. EBs were collected by rinsing the plate 
with media. EBs were then suspended in 20µl drops of Matrigel (Fisher) in 24-well 
tissue culture plates. EBs were cultured in DMEM with 3% KOSR (Gibco), Pen/Strep, 
Glutamax, NEAA, Sodium Pyruvate, and β-mercaptoethanol with 100ng/ml Activin A 
and some with 100ng/ml Activin A (R&D Systems) and 26ng/ml Bmp4 (R&D Systems) 
for four days. Media was changed after two days. EBs were then treated with All-Trans 
RA (Stemgent), SANTII, and bFGF (R&D Systems) for two days after which cells were 
grown in EB culture media with no supplements (Basal media) for 19 more days. Media 
was changed every other day.  
RNA Isolation and Quantitative RT-PCR  
 EBs were flash frozen immediately upon collection and stored at -80°C. RNA was 
isolated from cells with the Qiagen RNeasy Micro Kit or MagMax RNA Isolation Kit. 
Quantitative RT-PCR (qRT-PCR) was carried out using Roche FastStart SYBR Green 
Master Mix and the Applied Biosystems StepOnePlus Real-time PCR system (Life 
Technologies). Relative expression values were calculated as 2−ΔΔCt and values of 
controls were normalized to 1. Rn18s served as an internal control for normalization in 
all qRT-PCR experiments. All data are shown as the mean of three independent 
biological replicates; error bars represent s.e.m. Calculations and P-values (two-tailed, 
unpaired t-test) were generated in Microsoft Excel. Results were considered statistically 
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significant at P < 0.05. Graphs were generated using Prism 6. Primer sequences are 
listed in Table 3.1. 
Immunofluorescent Staining  
 For section in situ hybridization (ISH), differentiated EBs were fixed for 3 hours in 
4% paraformaldehyde in PBS at room temperature. EBs were then rinsed in PBS and 
immersed in 30% sucrose at 4°C overnight before embedding into optimal cutting 
temperature (OCT) media. Frozen sections 12 µm in size were cut, and slides were 
stored at −80°C. Slides were blocked for one hour at room temperature in 0.1% or 0.5% 
Triton X-100 in PBS (PBS-T) with 1% donkey serum and treated with primary antibody 
overnight at 4°C. On day two slides were washed in PBS-T, incubated with secondary 
antibody for two hours at room temperature, followed by a 10-minute wash in PBS-T 
with DAPI (Sigma Aldrich). Coverslips were added to the slides using Prolong Gold 
Antifade Reagent (Invitrogen). Primary and secondary antibodies used are listed in 
Supplementary Table 1. Slides were imaged using an Olympus BX-51 microscope. 
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Figure 3.1. Differentiation protocol. 
EBs were formed from mESCs using hanging drops for two days. EBs were then 
embedded in Matrigel and treated with Activin A for four days to induce endodermal 
differentiation. RA, SANT-2, and bFGF were added for two days to induce foregut, and 
then pancreas differentiation. After two days of treatment, EBs were cultured in media 
without growth factors and cells were collected for final analysis three weeks after RA, 
SANT-2, and bFGF treatment was started.  
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Figure 3.2. mESCs differentiate to endoderm.  
qRT-PCR and immunofluorescence analyses shows the expression of endodermal 
markers Foxa2 (A) and Sox17 (B). There is a decrease in expression of Vim compared 
to mESCs however there are mesenchymal cells present as shown by antibody staining 
for Vim (C). Scale bars 100 µM. Results are mean±s.e.m. (n≥4). 
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Figure 3.3. Both exocrine and endocrine pancreas cells are represented in in vitro 
differentiation.  
qRT-PCR shows that both Pdx1 (A) and Ins (B) are expressed and 
immunofluorescence analyses confirms the presence of  Pdx1- (A) and C-peptide-
positive (B) cells three weeks after treatment with RSF media. Exocrine cells are also 
represented as shown by the expression and protein staining of both Amy2 (C) and 
Cpa1 (D). Scale bars 100 µM. Results are mean±s.e.m. (n≥3). 
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Figure 3.4. qRT-PCR analyses for genes primarily expressed in other foregut 
derived organs.  
Pax8 (thymus) is expressed after 3 weeks of differentiation but Nkx2.1 (lung) and Cdx2 
(gut) are not expressed. Results are mean±s.e.m. (n≥5). 
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Figure 3.5. Hox genes are expressed and the Hox code is maintained in vitro.  
qRT-PCR analyses of the Hox 1, 2, 5, 6, 11, and 13 paralogous groups show that genes 
expressed in the pancreatic region of the embryo are expressed in culture at two and 
three weeks of differentiation. The Hox 1, 2, 11, and 13 groups, which function in the 
anterior and posterior regions of the embryo, are expressed at much lower levels 
compared to EB and endodermal stages. Results are mean±s.e.m. (n≥3). 
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Figure 3.6. Hox6 mutant ESCs differentiate to endoderm and exocrine cells 
normally but exhibit lower Ins+ cell populations.  
Endodermal genes Foxa2 and Sox17 are expressed comparably in both WT control and 
Hox6 mutant mESCs after treatment with Activin A (A). Hox6 mutant cells express 
similar amounts of Pdx1 (B) but less Ins (C) than WT control cells. qRT-PCR and 
immunofluorescence analyses show that there is no difference in the competency of 
Hox6 mutant and control mESCs differentiate to Amy2-positive (D) and Cpa1–positive 
(E) exocrine cells three weeks post RSF treatment. Scale bars 100 µM. Results are 
mean±s.e.m. *P<0.05 calculated by Student’s t-test (n≥3). 
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Figure 3.7. BMP4 increases the amount of mesoderm early in differentiation but 
does not increase the amount of Ins expression overall.  
Treatment of cells with both Activin A alone and with Activin A and Bmp4 produces 
populations with proportional amounts of endodermal Foxa2 gene expression (A). 
Treatment of cells with Bmp4 in addition to Activin A significantly increases the Vim-
positive population of mesenchymal cells (B). The amount of Ins expression and C-
peptide staining remains unchanged when cells are treated with Activin A alone or with 
both Activin A and Bmp4 (C). Two weeks after RSF treatment, the amount of Vim 
expression and Vim-positive mesenchyme (shown at three weeks post RSF treatment) 
is comparable between cells treated with and without Bmp4 (D). Scale bars 100 µM. 
Results are mean±s.e.m. (n≥4). 
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Table 3.1. List of qRT-PCR primers for cultured cells 
 
 
 
Gene Forward Primer Reverse Primer 
Sox17 GGCACAGCAGAACCCAGAT TTGTAGTTGGGGTGGTCCTG 
Vim AGAGAGAGGAAGCCGAAAGC TCCACTTTCCGTTCAAGGTC 
Foxa2 TAAAGTATGCTGGGAGCCGT TCATGTTGCTCACGGAAGAG 
Cdx2 AAACCTGTGCGAGTGGATG  TCTGTGTACACCACCCGGTA 
Pax8 CGGCGATGCCTCACAACTCG  CCGGATGCTGCCAGTCTCGT 
Nkx2.1 TACTGCAACGGCAACCTG GCCATGTTCTTGCTCACGTC 
Pdx1 CCACCCCAGTTTACAAGCTC TGTAGGCAGTACGGGTCCTC 
Ins GTGACCAGCTATAATCAGAGACCA CTCCCAAAGGGCAAGCAG 
Amy2 AGCCTTTTTCAAACTGGTGG TAAAGTGGCTGACAAAGCCC 
Cpa1 ACACGGGACCAAGTTCAAGT ACTTGATGCCCTGGCTGTAG 
HoxA1 AAAAGAAACCCTCCCAAAACA AGCTCTGTGAGCTGCTTGGT 
HoxB1 TTCGACTGGATGAAGGTCAA GGTGAAGTTTGTGCGGAGAC 
HoxD1 TGAAAGTGAAGAGGAACGCC TCTGTCAGTTGCTTGGTGCT 
HoxA2 GATGAAGGAGAAGAAGGCGG TGCCATCAGCTATTTCCAGG 
HoxA5 CAGGGTCTGGTAGCGAGTGT CTCAGCCCCAGATCTACCC 
HoxB5 CTGGTAGCGAGTATAGGCGG AGGGGCAGACTCCACAGATA 
HoxC5 TTCTCGAGTTCCAGGGTCTG ATTTACCCGTGGATGACCAA 
HoxA6 GTCTGGTAGCGCGTGTAGGT CCCTGTTTACCCCTGGATG 
HoxB6 GAGACCGAGGAGCAGAAGTG CAGGGTCTGGTAGCGTGTG 
HoxC6 CAGGGTCTGGTACCGAGAGTA TCCAGATTTACCCCTGGATG 
HoxA11 AGGCTCCAGCCTACTGGAAT CCTTTTCCAAGTCGCAATGT 
HoxC11 GCGGCCGACGAGCTTAT TTTTTCATGAGGATCTCAGTGA
CTGT 
HoxD11 ACACCAAGTACCAGATCCG AGTGAGGTTGAGCATCCGAG 
HoxA13 AGCGGCTACTACCCGTGC  CGGTGTCCATGTACTTGTCG 
HoxC13 TCAGGTGTACTGCTCCAAGG CTCACTTCGGGCTGTAGAGG 
HoxD13 CCCATTTTTGGAAATCATCC TGGTGTAAGGCACCCTTTTC 
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Table 3.2. Primary antibodies  
 
Antibody Dilution Vendor Catalog Number 
Rabbit anti-Amy 1:100 Sigma Aldrich 090M4801 
Guinea pig anti-Pdx1 1:500 Abcam AB47308 
Mouse anti-Vim 1:200 Sigma Aldrich 091M4791 
Rabbit anti-Cpa1 1:100 Rockland Immunochemicals 100-4152 
Sox17 1:500 R&D Systems AF1924 
C-peptide 1:100 Cell Signaling 4593S 
Foxa2 1:1,000 Seven Hills Bioreagents WRAB-FOXA2 
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CHAPTER 4 
 
 
CONCLUSION 
 
 
Summary of findings 
Hox6 genes are expressed in the mesenchyme of the pancreas and play a 
critical role in the differentiation of endocrine cells. At no point did we observe co-
expression of Hox6 with markers for endocrine cells, epithelium, blood vessels, 
neurons, or smooth muscle in the pancreas at embryonic stages. Although the exocrine 
compartment of the Hox6 mutant pancreas is largely normal, we observed some minor 
early developmental defects. The Hox6 mutant pancreas exhibited impaired branching 
of the epithelium at early stages with an apparent disruption of proper ductal plexus 
remodeling at early embryonic stages. This defect may be caused by the failure of 
MPCs of the pancreas to differentiate normally, as suggested by prolonged co-
localization of Sox9 and Hnf1β. These proteins are associated with multipotency in the 
tip cells in the pancreas. At later stages, the expression of Sox9 and Hnf1β normalizes, 
and these proteins are excluded from the tip cells, suggesting a delay in the transition of 
tip MPCs to unipotent acinar cells. This delay in MPC maturation does not result in 
extensive branching defects overall.  
 The endocrine compartment is significantly reduced throughout development and 
by E18.5, the Hox6 mutant pancreas exhibits a greater than 90% decrease in 
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expression levels of all five endocrine hormones. This does not appear to be a defect in 
either the specification or delamination of Ngn3+ endocrine progenitor cells. We were 
unable to detect any defects in Ngn3 expression, the abundance of Ngn3+ cells, or the 
ability of Ngn3+ cells to successfully turn off Sox9 expression as they leave the ductal 
epithelium. There is a significant loss of several endocrine specific genes required for 
proper endocrine cell maturation such as MafA, MafB, Nkx6.1, NeuroD, Isl1, and ChgA. 
This suggests that the loss of mature endocrine cells occurs during the maturation 
process following the proper delamination of Ngn3+ endocrine progenitors from the 
ductal epithelium.  
 There are multiple developmental signaling pathways active in the mesenchyme 
that are critical for pancreas development including Fgf, Bmp, Notch, and Wnt (Puri and 
Hebrok, 2010). Microarray analysis performed at E12.5 comparing control and Hox6 
mutant pancreata identified defects in the Wnt signaling pathway, while other 
developmental pathways were relatively normal. Consistent with the microarray 
analysis, qRT-PCR showed significant decreases in expression of Wnt signaling 
pathway members Wnt5a, Sfrp3, and Dkk1 at E12.5 in the Hox6 mutant pancreas while 
members of the Fgf, Bmp and Notch pathways were unchanged.  
Wnt5a is a ligand expressed in both the epithelium and mesenchyme of the 
pancreas, and Sfrp3 and Dkk1 are Wnt inhibitors expressed in endocrine cells and the 
epithelium of the pancreas (Heller et al., 2002). ISH analyses showed that expression of 
Wnt5a is dramatically decreased in the pancreas mesenchyme in the Hox6 mutant 
pancreas while expression of Wnt5a in the epithelium was unchanged. These data 
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support a role for Wnt5a downstream of Hox6 in the mesenchyme and may in fact be a 
direct target.  
In addition to demonstrating the importance of Hox6 genes in endocrine 
pancreas development in vivo, we show a role for Hox6 in the in vitro differentiation of 
insulin-producing cells. We utilized a method of three-dimensional culture to encourage 
cell-cell interactions as a way to better mimic the in vivo environment of β-cell 
development and encouraged the formation of mesoderm, in addition to endoderm, in 
order to investigate the effect of genes expressed solely in the mesoderm. We first 
induced mESCs to form EBs, which are three-dimensional spheres capable of giving 
rise to all three germ layers. Next, we compared the ability of WT and Hox6 null mESCs 
to differentiate to insulin-producing cells and found that there was significantly less Ins 
expression in the Hox6 mutant cells. Equivalent amounts of endoderm markers, 
exocrine markers, and Pdx1 was detected in control and mutant cultures indicating that 
the lack of Ins expression in the mutant cultures was not due to an inability of these 
mutant cells to differentiate in general. These data support an important role for Hox6 
genes, expressed just in the mesoderm, in the efficiency of mESCs to differentiate to 
insulin-producing cell in vitro.  
Given the important role of the mesenchyme in β-cell differentiation, we also 
investigated the effect of manipulating the amount of mesenchyme throughout our 
differentiation protocol. Treating cells with Bmp4 has been shown to induce mesoderm 
differentiation in culture (Purpura et al., 2008; Sakurai et al., 2009). We treated the EBs 
with both Bmp4 and Activin A to induce a combination of mesoderm and endoderm 
respectively. Our data show that this significantly increases the population of mesoderm 
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without significantly inhibiting endoderm differentiation. Despite a significant increase in 
the abundance of mesoderm early in differentiation, there was no significant increase in 
the level of Ins expression compared to cultures without Bmp4 treatment. Additional 
analyses revealed that there was a comparable amount of mesenchyme produced 
regardless of the initial endoderm/mesoderm differentiation (Activin A or Activin A and 
Bmp4 treatment). This, unfortunately, may have masked any role of additional early 
mesoderm differentiation, as the signals for insulin-producing cells are critical at later 
stages in differentiation when the amount of mesenchyme was comparable between 
treatment conditions. Taken together, we have shown that mesenchymal cells present 
during directed differentiation cultures have a significant influence on the differentiation 
of the surrounding cells. Cell-cell signaling between different populations can have 
significant effects on the differentiation of desired cells, and including the proper 
complementary cells in culture may greatly impact the efficiency of successfully 
generating cells for use in the treatment of diabetes.  
 
Contributions to the field 
 
 While the importance of the mesenchyme in pancreas development has been 
appreciated for more than 50 years, the specific molecular signals involved in 
mesenchymal to epithelial crosstalk remain largely unknown. Here we show that Hox6 
genes are expressed in the pancreas mesenchyme and are critical for endocrine 
pancreas development both in vivo and in vitro. Prior data on the functional roles for 
Hox6 was limited to anteroposterior patterning, rib formation, and neuronal development 
(McIntyre et al., 2007; Mallo et al., 2010; Philippidou and Dasen, 2013). Our data now 
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identify a novel role for Hox6 genes in the pancreas, an organ without a previously 
reported role for Hox genes. Specifically, we show that Hox6 is required for proper 
Wnt5a expression in the mesenchyme, which directs endocrine cell differentiation in the 
mouse. These data show a regulatory relationship between Hox and Wnt signaling in 
organ development, a theme that is becoming more apparent (Kuss et al., 2014; Hrycaj 
et al., 2015).  
In addition to their critical role in endocrine pancreas development in vivo, we 
also show that Hox6 mutant mESCs are deficient in their ability to differentiate to 
insulin-producing cells in vitro. These data show a critical role for signals produced just 
in the mesoderm in directed differentiation experiments. The in vitro differentiation of 
functional β-cells is a very promising strategy to treat diabetes. Knowledge of the 
mesenchymal signals that promote β-cell differentiation in vivo have been critical to 
developing efficient protocols of differentiating insulin-producing cells from hESCs and 
iPSCs (Pagliuca and Melton, 2013). Uncovering the mesenchymal signals critical for β-
cell differentiation, maturation, and function will be paramount to successfully 
developing functional β-cells to treat diabetes. Our work adds to this knowledge by 
uncovering another mesenchymal factor, Hox6, with a critical role in β-cell development. 
 
Future Directions 
 
 Our work in pancreas development in vivo has shown a critical interaction 
between Hox6 and Wnt signaling in the mesenchyme and endocrine cells of the 
pancreas. With the inactivation of Hox6 in the mesenchyme and subsequent disruption 
in Wnt signaling, there is a dramatic reduction in the abundance of hormone producing 
endocrine cells. Despite this dramatic loss of endocrine cells, there was no change in 
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Ngn3-positive progenitor cells, proliferation of endocrine progenitors or mature 
endocrine cells, or increased apoptosis. One question that remains is the fate of those 
endocrine progenitor cells that do not mature to hormone producing cells. The fate of 
these cells could be investigated using lineage trace techniques. The Ngn3-Cre allele 
(Desgraz and Herrera, 2009) could be bred into the Hox6 mutant mouse colony to drive 
expression of a reporter allele in Hox6 triple mutants. We could then co-stain with a 
pan-endocrine marker such as ChgA to identify those reporter-positive cells that have 
matured to endocrine cells, while also identifying reporter-positive, ChgA-negative 
endocrine progenitor cells that did not mature. It will be interesting to determine if these 
cells remain semi-differentiated in the mesenchyme, re-insert back into the duct, or 
localize somewhere else.   
 Our data has shown that with the inactivation of Hox6 function, there is a loss of 
Wnt5a expression in the mesenchyme and a dramatic loss of hormone-producing 
endocrine cells in vivo. We demonstrate the importance of Wnt5a in pancreas explant 
cultures showing that Wnt5a is sufficient to rescue endocrine cell differentiation. To 
further investigate the role of Wnt5a in the mesenchyme, we could use one of two 
techniques. First, we could take Wnt5a null mesenchyme from Wnt5a global knockout 
embryos and recombine it with WT, stage matched epithelium in culture. Second, we 
could genetically inactivate Wnt5a function specifically in the mesenchyme of the 
pancreas. Utilizing tools such as the Nkx3.2-Cre (Landsman et al., 2011) mouse and 
crossing it to a conditional Wnt5a knockout mouse (Miyoshi et al., 2012) would allow us 
to examine the specific role of Wnt5a function in the mesenchyme. Using one (or both) 
of these methods, we would first compare the phenotypes from mesenchymal Wnt5a 
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knockout mice to phenotypes observed in the Hox6 mutants including, endocrine cell 
abundance, Wnt inhibitor expression, and branching. The results of this experiment 
would allow us to assess several points. First, does Wnt5a affect the expression of Wnt 
inhibitors Sfrp3 and Dkk1? Second, is the loss of endocrine cells and branching 
disruptions both caused by the loss of Wnt5a? Third, is Wnt5a necessary for endocrine 
cell differentiation, or just sufficient to rescue the Hox6 mediated loss of endocrine cell 
differentiation? If the phenotypes observed in mesenchyme specific loss of Wnt5a do 
not match that of the Hox6 phenotypes, we would hypothesize that there are other 
factors affected in the pancreas mesenchyme that act in parallel to Wnt5a. These may 
include additional Wnt ligands such as Wnt2b or Wnt11, which have reduced levels of 
expression in the Hox6 mutant pancreas at later stages than the initial reduction of 
Wnt5a expression (Chapter 2).  
It has been recently shown that Hox proteins are capable of inducing the 
expression of Wnt5a (Kuss et al., 2014), but further work is needed to determine if 
Wnt5a is a direct target of Hox6 proteins in the pancreas mesenchyme. Unfortunately, 
the lack of reliable antibodies for ChIP experiments makes this difficult. An alternative 
approach to determine the binding sites of Hox6 is to generate tagged Hox6 proteins in 
vitro as a method to utilize commercially available antibodies for ChIP and/or ChIP-Seq.  
We have shown a loss of Sfrp3 and Dkk1 expression in Ngn3-positive endocrine 
progenitor cells at early stages in development. We do not know if expression of these 
inhibitors is activated in Wnt5a mediated rescue of endocrine cell differentiation due to 
the experimental design. Since pancreas explants were collected six days after 
dissection, at what equates to E18.5, we were unable to detect Wnt inhibitor 
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localization. We could test the capability of Wnt5a treatment to promote Wnt inhibitor 
expression by collecting the pancreas explants after two days in culture instead of six. 
The quantity of Wnt inhibitor detection could be quantified similarly to how endocrine 
cell abundance was analyzed to assess inhibitor abundance between control and Hox6 
mutant pancreata. 
While we have shown that several members of the Wnt signaling pathway are 
disrupted in the Hox6 mutant pancreas, we have been unable to demonstrate changes 
in overall Wnt signaling activity. qRT-PCR for readouts such as Axin2 has not shown 
any significant changes in expression between control and Hox6 mutant pancreata. This 
may be due to the small number of cells (i.e. the endocrine progenitor cells) with 
disrupted Wnt activity, while the rest of the pancreas is relatively unaffected. One 
method to assess changes in Wnt activity in specific cells would be to cross our Hox6 
mutant mice with Wnt reporter mice such as the BAT-gal or Axin2-LacZ animals 
(Jonckheere et al., 2008) to investigate the presence or absence of Wnt activity in 
specific cells such as Ngn3-positive endocrine progenitor cells. These reporter mice 
could support our hypothesis that Ngn3-positive endocrine progenitor cells in the Hox6 
mutant have excess Wnt signaling, whereas Ngn3-positive cells in the control lack Wnt 
activity.  
The role of Wnt inhibitors in endocrine cell differentiation is also largely 
uncharacterized, and to provide insights into their function we could investigate 
endocrine cell defects in Dkk1 and Sfrp3 knockout mice. Mice have been generated 
with a knockout of each of these genes (Mukhopadhyay et al., 2001; Jang et al., 2013), 
but there has been no analysis of the endocrine pancreas in either. It could be that a 
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double knockout of both Dkk1 and Sfrp3 is necessary to see an effect due to functional 
redundancy of these inhibitors. If there is no detectable endocrine cell phenotype in the 
single mutant of either Dkk1 or Sfrp3 mutant mice, it would be interesting to cross these 
two knockout lines together to determine if the endocrine pancreas is significantly 
affected. This would show a critical role for Wnt inhibitors in the differentiation of 
endocrine cells of the pancreas.  
Hox genes have been shown to be critical for AP patterning, and the LOF of Hox 
paralogous groups results in anterior homeotic transformations (Lewis, 1978). One 
possible cause of the observed pancreas phenotypes might be the anterior homeotic 
transformation of the pancreas mesenchyme to another type of mesenchyme normally 
produced in an anterior region. Further analysis of our microarray data could provide 
clues as to the nature of the mesenchyme present in Hox6 mutant pancreata compared 
to controls. Microarray analyses could also be performed on physically separated 
mesenchyme from E11.5 pancreata and other organs such as E11.5 lungs. We could 
then compare the expression profiles of mesenchyme from Hox6 mutant pancreas, WT 
control pancreas, and other WT organs. This would allow us to determine if the Hox6 
mutant pancreas mesenchyme is more similar to control mesenchyme or to that of other 
organs.  
We have shown that Hox6 genes are expressed through most of development, 
however their expression declines and is eventually undetected at later stages of 
development by qRT-PCR. It would be interesting to investigate possible Hox6 
expression in further detail at these later stages and at adult stages. It has been 
previously shown that the percentage of the pancreas that is made up of mesenchyme 
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dramatically decreases over time (Landsman et al., 2011). Does the level of Hox6 
expression actually decreases in the pancreas mesenchyme or is this an artifact of the 
increase in the proportion of Hox6-negative epithelium compared to Hox6-positive 
mesenchyme? The physical composition of the organ makes it extremely difficult, if not 
impossible, to dissect the mesenchyme from the epithelium at these late stages. To 
circumvent this difficulty, we could utilize Hoxb6CreERT;Rosa26-tdTomato embryos and 
induce recombination at late stages to determine if Hox6 is expressed at later stages of 
pancreas development. For more detailed analyses of mesenchymal expression, cell 
sorting could be utilized to separate the mesenchyme from the epithelium by the 
detection of the red fluorescent protein. qRT-PCR analysis of RNA extracted just from 
pancreas mesenchyme would allow us to determine if Hox6 expression does in fact 
decline through development, or if the signal is lost in the overwhelming majority of the 
Hox6-negative pancreas epithelium.  
We could also take advantage of Hoxb6CreERT;Rosa26-tdTomato mice to 
examine Hox6 expression in adult stages. If Hox6 expression does not persist into adult 
stages it would be interesting to assess whether Hox6 expression can be reactivated in 
pancreas injury. We could investigate whether the developmental pathways involving 
Hox6 function in the mesenchyme are utilized in adult stages to help to repair the 
pancreas. The generation of a mouse with a fluorescent protein knocked in to a Hox6 
locus would also allow us to visualize real time expression of Hox6 at any time point 
desired, and to perform live imaging after pancreas injury.  
In addition to the necessary role of mesenchymal factors in endocrine cell 
development in vivo, our work in the differentiation of mESCs to insulin-producing cells 
	   103	  
has shown a significant role for factors produced by the mesenchyme in vitro. While our 
study showed that inducing mesenchyme differentiation early in the protocol had no 
effect on the efficiency of IPC differentiation, it is possible that manipulating the 
mesenchyme at different stages could play an important role. Sneddon et al. showed 
that providing progenitor cells at different stages of differentiation with the appropriate 
mesenchyme significantly enhanced the proliferative capacity of these cells (Sneddon et 
al., 2012). It is possible that inducing or providing appropriate mesenchyme to 
progenitor cells may greatly increase the number of functional β-cells generated, 
providing a greater pool of cells to use in cellular therapies of diabetes.  
After demonstrating a critical role for Wnt5a in endocrine cell differentiation in 
vivo, it would be interesting to investigate whether Wnt5a can have an effect on insulin-
producing cell differentiation in vitro. Wnt5a could be added to the media after treatment 
with RA, bFGF, and SANT-2 when endocrine cell differentiation is starting to occur. We 
could compare the efficiency of differentiation in WT control cells with or without Wnt5a 
in the media. This would allow us to assess any beneficial role of adding a non-
canonical Wnt ligand to the media. We could also add Wnt5a to the differentiation 
media in Hox6 mutant mESC cultures to investigate whether Wnt5a is capable of 
rescuing endocrine cell differentiation in vitro similar to in vivo.  
Utilizing animal models, such as the mouse and zebrafish, has provided insights 
into pancreas and endocrine cell development, however there are critical differences 
between these animals and human endocrine pancreas development (Nair and Hebrok, 
2015). While animal models are important and accessible tools for the study of β-cell 
development and function, more will need to be learned about human β-cell 
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development and function to provide greater insights into developing new treatments for 
diabetes. It will be interesting to analyze genetic data from diabetic patients to 
determine if any contain mutations of Hox6 genes. While many Hox6 genes will need to 
be disrupted to see any dramatic phenotype by themselves, it is possible that LOF of 
one or more Hox6 genes in parallel to other critical endocrine cell differentiation factors 
may have a cumulative effect on β-cell production in Type I diabetic patients.  
 Current protocols to develop functional β-cells in vitro have made significant 
strides to generate cells for treatment, although optimization of these protocols is 
needed (Pagliuca et al., 2014). One major issue will be the generation of a pure 
population of insulin-producing cells. This will be necessary to prevent the presence of 
remaining multipotent progenitor cells from forming cysts or tumors in the patient 
(Pagliuca and Melton, 2013). A more complete understanding of the signals critical for 
directing endocrine cell differentiation via mesenchymal to epithelial crosstalk may be 
the key factor in establishing clinical protocols for the generation of functional β-cells to 
treat diabetes.  
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APPENDIX: PUBLICATIONS AND MANUSCRIPTS 
 
Chapter 2 is based on a manuscript in revision titled “Mesenchymal Hox6 Function is 
Required for Pancreatic Endocrine Cell Differentiation” with authors listed as Brian M. 
Larsen, Steven M. Hrycaj, Micaleah Newman, Ye Li and Deneen M. Wellik. 
 
Chapter 3 is based on a manuscript in submission titled “Hox6 function in the in vitro 
differentiation of mESCs to insulin-producing cells” with authors listed as Brian M. 
Larsen, Micaleah Newman, Derek T. Lukacs, Jason R. Spence, and Deneen M. Wellik. 
 
Hrycaj SM, Dye BR, Baker NC, Larsen BM, Burke AC, Spence JR, Wellik DM. Hox5 
Genes Regulate the Wnt2/2b-Bmp4-Signaling Axis during Lung Development. Cell Rep. 
2015 Aug 11;12(6):903-12. doi: 10.1016/j.celrep.2015.07.020. Epub 2015 Jul 30. 
PubMed PMID: 26235626; PubMed Central PMCID: PMC4536095.
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